{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T04:29:44.371714",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "eb1983b1-d98c-4064-b53f-58dd99cbe3d1",
    "instanceType": "Study",
    "versions": [
      {
        "id": "e9965cd7-8aff-4fd8-9e19-fb25837650b1",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "f6dfa4ed-a190-4cc7-8cd3-59a4ad12cc40",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "4f8053c7-e15e-490d-af98-342ea58389b8",
              "standardCode": {
                "id": "a87f9419-ccf6-475d-ad34-fea81db1f91a",
                "code": "Double Blind",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Double Blind",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "2203dae5-e4f9-449a-8ed2-8297a78b55e4",
                "name": "Cohort 1: 20vPnC Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 60 years and older receive 20vPnC at Visit 1 followed by Saline at Visit 2",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "66688b33-1c0a-46d3-bc56-596a7f67037a",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "1b7d1b97-1e29-4f51-b611-eb8fd14db5ea",
                "name": "Cohort 1: Control Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 60 years and older receive 13vPnC at Visit 1 followed by PPSV23 at Visit 2",
                "type": {
                  "id": "C174267",
                  "code": "C174267",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Active Comparator Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "ce6fa8d4-3e79-4ab2-b267-cf7f54e48ce7",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "41383d25-1648-4c14-9589-3c2bf303c4cf",
                "name": "Cohort 2: 20vPnC Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 50-59 years receive a single dose of 20vPnC at Visit 1",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "914fc3ee-79b0-4766-b44b-843c1125de09",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "707b3fa3-d0ee-4449-8600-540c6c113d40",
                "name": "Cohort 2: 13vPnC Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 50-59 years receive a single dose of 13vPnC at Visit 1",
                "type": {
                  "id": "C174267",
                  "code": "C174267",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Active Comparator Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "3cab5c3a-2908-4b45-974c-20b53c8b5b24",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "431c9a9c-5b20-4366-9fb1-df9b7ba99e34",
                "name": "Cohort 3: 20vPnC Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 18-49 years receive a single dose of 20vPnC at Visit 1",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "1ce55cad-d2e7-4d0a-af03-cd8c7c828532",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "abd073a5-a929-4500-b97a-ff8a90045763",
                "name": "Cohort 3: 13vPnC Group",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants 18-49 years receive a single dose of 13vPnC at Visit 1",
                "type": {
                  "id": "C174267",
                  "code": "C174267",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Active Comparator Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "ddcad409-065b-4436-a4ad-38c5a77079b1",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "57b1e250-18b3-4964-a436-43596f0585ed",
                "name": "Cohort 1",
                "instanceType": "StudyCohort",
                "characteristic": "Adults 60 years of age and older"
              },
              {
                "id": "d1e7a78c-edc4-42c2-91bd-02fccc5fe4dd",
                "name": "Cohort 2",
                "instanceType": "StudyCohort",
                "characteristic": "Adults 50 through 59 years of age"
              },
              {
                "id": "232af0d8-54d4-44e1-8e31-2f023f046917",
                "name": "Cohort 3",
                "instanceType": "StudyCohort",
                "characteristic": "Adults 18 through 49 years of age"
              }
            ],
            "studyCells": [
              {
                "id": "db63dccb-af62-41d6-b7bb-bfa8afc61004",
                "armId": "2203dae5-e4f9-449a-8ed2-8297a78b55e4",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "1558b737-2fcc-4be0-a289-ccf5874d1f57"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ad3e6201-dd4f-4452-b4e5-c8716859635c",
                "armId": "2203dae5-e4f9-449a-8ed2-8297a78b55e4",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "de5316d6-0c1e-41b0-a752-03e2d8bfe2f3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "db2e608c-17ff-44f7-b8fc-8b03d3b10c3a",
                "armId": "2203dae5-e4f9-449a-8ed2-8297a78b55e4",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "877cf4cf-ec18-45c6-9aab-534fbac343b2"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "3db35c4f-0170-45ff-8408-decb86e6da45",
                "armId": "2203dae5-e4f9-449a-8ed2-8297a78b55e4",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "dd3e251e-1451-4944-a20f-127e3820c94c"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "dc25c5a6-4638-4faa-a4a8-619eed68ca5b",
                "armId": "1b7d1b97-1e29-4f51-b611-eb8fd14db5ea",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "07feeaf0-bcc6-43c3-8964-edbb5b8ee62a"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "5615f834-f4e6-4ffb-88e1-242f784e354d",
                "armId": "1b7d1b97-1e29-4f51-b611-eb8fd14db5ea",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "a4f685a5-9463-4916-b21f-56acfb416e03"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "63077bea-3109-4a31-8bee-4a030bd466fe",
                "armId": "1b7d1b97-1e29-4f51-b611-eb8fd14db5ea",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "d7feb381-a22e-4ddb-a6b8-e958b2a92f98"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "b1493781-a754-406c-abcc-273354415da8",
                "armId": "1b7d1b97-1e29-4f51-b611-eb8fd14db5ea",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "7a27b3a4-f9b2-4150-b839-3547747b0b91"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "21689391-68eb-47af-bbc8-6c2c0cb6a46d",
                "armId": "41383d25-1648-4c14-9589-3c2bf303c4cf",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "b5f2c815-8629-46a8-ae92-b4811d3b8561"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "1d0fe02a-4f0e-40fa-a5df-d59c59e61f87",
                "armId": "41383d25-1648-4c14-9589-3c2bf303c4cf",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "678f41ad-2aa4-4d88-832a-f88b2511823d"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "8a04e101-2675-469c-88ce-25ff7a9a6d22",
                "armId": "41383d25-1648-4c14-9589-3c2bf303c4cf",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "7b857376-ab84-42da-93c2-3a10308d4c5e"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "8f5398b2-ca70-46a9-91b3-0d31b1c90149",
                "armId": "41383d25-1648-4c14-9589-3c2bf303c4cf",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "62013dfd-0060-45fa-9a7a-69e61fe8282b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "06b488b5-8a14-4bb8-8823-0e21801ade04",
                "armId": "707b3fa3-d0ee-4449-8600-540c6c113d40",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "a26f52c0-14fa-41f5-8414-56f81d1b5ee9"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "2f26ca0c-b7a9-4562-89cc-e6b10f043d10",
                "armId": "707b3fa3-d0ee-4449-8600-540c6c113d40",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "8dc87e41-6873-45ed-8b0b-4ea9075ff3d7"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "a0a22e13-5071-49ea-b4d5-7a22901f7813",
                "armId": "707b3fa3-d0ee-4449-8600-540c6c113d40",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "ca80a294-f1e4-4682-b2da-5cf6797f8b09"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "19d4cfe7-679f-443b-a982-d8ed176172ca",
                "armId": "707b3fa3-d0ee-4449-8600-540c6c113d40",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "e71110bf-4428-40f0-a5c2-0bcaad6a3b1b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "e7120e43-09f9-4591-92c4-8b68a55dd7ca",
                "armId": "431c9a9c-5b20-4366-9fb1-df9b7ba99e34",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "55b79bcb-a40c-49e5-a7de-55d0c614af7a"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "d646c5f5-171c-42f8-a71f-2533834edcd3",
                "armId": "431c9a9c-5b20-4366-9fb1-df9b7ba99e34",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "689b7386-e61d-4439-9090-e416a2d06581"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "13b356b0-590c-4f98-8121-ce13c21f57c3",
                "armId": "431c9a9c-5b20-4366-9fb1-df9b7ba99e34",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "bb8021d9-d83a-48f0-b297-1f5af5639395"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "22906949-f04f-4cc9-b0b5-5d18055b36ce",
                "armId": "431c9a9c-5b20-4366-9fb1-df9b7ba99e34",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "94b554a5-d6bc-4302-9e32-8f07fcafbd7f"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ef49f1f2-0fd9-492a-b809-d75847b31959",
                "armId": "abd073a5-a929-4500-b97a-ff8a90045763",
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "elementIds": [
                  "40175552-f44e-40cc-80aa-107a61e44173"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "7c9ab981-e94b-4890-be27-c9233d31d30f",
                "armId": "abd073a5-a929-4500-b97a-ff8a90045763",
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "elementIds": [
                  "2b3de8da-f090-44c0-8f90-96faafbb393a"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "9f7a348d-5bca-4623-99d4-ed69d81291a9",
                "armId": "abd073a5-a929-4500-b97a-ff8a90045763",
                "epochId": "0c5d5ac4-9c35-43a7-930e-9fb8bc14c1ae",
                "elementIds": [
                  "70e1cc75-865e-43cd-bd3e-c61f38e1fd4b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "9326cfdc-fed1-489e-9524-2d7c6b98dec4",
                "armId": "abd073a5-a929-4500-b97a-ff8a90045763",
                "epochId": "8b4d6516-f09b-4c56-83b4-e70d2b99a4c2",
                "elementIds": [
                  "a29ee6f5-8c05-4fbb-9ec1-884c9c78f454"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "1558b737-2fcc-4be0-a289-ccf5874d1f57",
                "name": "Cohort 1: 20vPnC Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: 20vPnC Group during Vaccination 1"
              },
              {
                "id": "de5316d6-0c1e-41b0-a752-03e2d8bfe2f3",
                "name": "Cohort 1: 20vPnC Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: 20vPnC Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "877cf4cf-ec18-45c6-9aab-534fbac343b2",
                "name": "Cohort 1: 20vPnC Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: 20vPnC Group during Follow-up"
              },
              {
                "id": "dd3e251e-1451-4944-a20f-127e3820c94c",
                "name": "Cohort 1: 20vPnC Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: 20vPnC Group during 6-Month Safety Collection"
              },
              {
                "id": "07feeaf0-bcc6-43c3-8964-edbb5b8ee62a",
                "name": "Cohort 1: Control Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: Control Group during Vaccination 1"
              },
              {
                "id": "a4f685a5-9463-4916-b21f-56acfb416e03",
                "name": "Cohort 1: Control Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: Control Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "d7feb381-a22e-4ddb-a6b8-e958b2a92f98",
                "name": "Cohort 1: Control Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: Control Group during Follow-up"
              },
              {
                "id": "7a27b3a4-f9b2-4150-b839-3547747b0b91",
                "name": "Cohort 1: Control Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 1: Control Group during 6-Month Safety Collection"
              },
              {
                "id": "b5f2c815-8629-46a8-ae92-b4811d3b8561",
                "name": "Cohort 2: 20vPnC Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 20vPnC Group during Vaccination 1"
              },
              {
                "id": "678f41ad-2aa4-4d88-832a-f88b2511823d",
                "name": "Cohort 2: 20vPnC Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 20vPnC Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "7b857376-ab84-42da-93c2-3a10308d4c5e",
                "name": "Cohort 2: 20vPnC Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 20vPnC Group during Follow-up"
              },
              {
                "id": "62013dfd-0060-45fa-9a7a-69e61fe8282b",
                "name": "Cohort 2: 20vPnC Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 20vPnC Group during 6-Month Safety Collection"
              },
              {
                "id": "a26f52c0-14fa-41f5-8414-56f81d1b5ee9",
                "name": "Cohort 2: 13vPnC Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 13vPnC Group during Vaccination 1"
              },
              {
                "id": "8dc87e41-6873-45ed-8b0b-4ea9075ff3d7",
                "name": "Cohort 2: 13vPnC Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 13vPnC Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "ca80a294-f1e4-4682-b2da-5cf6797f8b09",
                "name": "Cohort 2: 13vPnC Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 13vPnC Group during Follow-up"
              },
              {
                "id": "e71110bf-4428-40f0-a5c2-0bcaad6a3b1b",
                "name": "Cohort 2: 13vPnC Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 2: 13vPnC Group during 6-Month Safety Collection"
              },
              {
                "id": "55b79bcb-a40c-49e5-a7de-55d0c614af7a",
                "name": "Cohort 3: 20vPnC Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 20vPnC Group during Vaccination 1"
              },
              {
                "id": "689b7386-e61d-4439-9090-e416a2d06581",
                "name": "Cohort 3: 20vPnC Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 20vPnC Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "bb8021d9-d83a-48f0-b297-1f5af5639395",
                "name": "Cohort 3: 20vPnC Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 20vPnC Group during Follow-up"
              },
              {
                "id": "94b554a5-d6bc-4302-9e32-8f07fcafbd7f",
                "name": "Cohort 3: 20vPnC Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 20vPnC Group during 6-Month Safety Collection"
              },
              {
                "id": "40175552-f44e-40cc-80aa-107a61e44173",
                "name": "Cohort 3: 13vPnC Group - Vaccination 1",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 13vPnC Group during Vaccination 1"
              },
              {
                "id": "2b3de8da-f090-44c0-8f90-96faafbb393a",
                "name": "Cohort 3: 13vPnC Group - Vaccination 2 (Cohort 1 only)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 13vPnC Group during Vaccination 2 (Cohort 1 only)"
              },
              {
                "id": "70e1cc75-865e-43cd-bd3e-c61f38e1fd4b",
                "name": "Cohort 3: 13vPnC Group - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 13vPnC Group during Follow-up"
              },
              {
                "id": "a29ee6f5-8c05-4fbb-9ec1-884c9c78f454",
                "name": "Cohort 3: 13vPnC Group - 6-Month Safety Collection",
                "instanceType": "StudyElement",
                "description": "Treatment period for Cohort 3: 13vPnC Group during 6-Month Safety Collection"
              }
            ],
            "maskingRoles": [
              {
                "id": "a9babe32-2401-4369-9594-2b0d7061d530",
                "text": "Subject is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "a60643b8-f4e4-491d-bbd8-ab84961438ea",
                "text": "Investigator is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "9b6aa161-08f9-4e2b-ab25-f8124b141bb9",
                "text": "Outcome Assessor is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "93b14bfb-f6d9-418d-af9b-4a704f29d6ee",
                "text": "Caregiver is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "15310072-243a-4803-9125-04813c6cb600",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e071439c-7508-47bb-a102-98eebdd9722e",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent",
                "nextId": "675ac8bd-01b8-4c70-a873-866c3c4c8912"
              },
              {
                "id": "675ac8bd-01b8-4c70-a873-866c3c4c8912",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5bffb81e-3a3d-47fe-a652-972f055ea34a",
                "instanceType": "EligibilityCriterion",
                "name": "Compliance",
                "previousId": "15310072-243a-4803-9125-04813c6cb600",
                "nextId": "2f6d4c00-da15-4c6a-87d1-3c0dd28a6c5c"
              },
              {
                "id": "2f6d4c00-da15-4c6a-87d1-3c0dd28a6c5c",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4cc2f865-f722-4920-bbce-7fd491faf035",
                "instanceType": "EligibilityCriterion",
                "name": "Availability",
                "previousId": "675ac8bd-01b8-4c70-a873-866c3c4c8912",
                "nextId": "7d34f3da-2abc-4fa4-9f9f-52ceb77610c4"
              },
              {
                "id": "7d34f3da-2abc-4fa4-9f9f-52ceb77610c4",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6be66120-84e9-4cd6-90b2-355ff0c7c136",
                "instanceType": "EligibilityCriterion",
                "name": "Age Cohorts",
                "previousId": "2f6d4c00-da15-4c6a-87d1-3c0dd28a6c5c",
                "nextId": "f0a6abf2-3275-4773-9dc4-e5195a12a4b2"
              },
              {
                "id": "f0a6abf2-3275-4773-9dc4-e5195a12a4b2",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8298ba18-c983-4a47-9b97-2aa4b6f17067",
                "instanceType": "EligibilityCriterion",
                "name": "Stable Disease",
                "previousId": "7d34f3da-2abc-4fa4-9f9f-52ceb77610c4",
                "nextId": "5700e394-fbf8-47ed-864e-9926ac1a86ab"
              },
              {
                "id": "5700e394-fbf8-47ed-864e-9926ac1a86ab",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2e1b6914-bdcd-4624-a07f-e066071f471a",
                "instanceType": "EligibilityCriterion",
                "name": "Contraception",
                "previousId": "f0a6abf2-3275-4773-9dc4-e5195a12a4b2"
              },
              {
                "id": "f4236c4c-8aa1-4395-9c80-e66b96ed7104",
                "identifier": "1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b50fe4db-6262-4025-97d0-83dce092fd46",
                "instanceType": "EligibilityCriterion",
                "name": "Site Staff Exclusion",
                "nextId": "b80d0e8c-1540-473a-be7c-b750b745526d"
              },
              {
                "id": "b80d0e8c-1540-473a-be7c-b750b745526d",
                "identifier": "2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "76c0e741-0b7e-46ab-9026-df72c61b7291",
                "instanceType": "EligibilityCriterion",
                "name": "Investigational Product Participation",
                "previousId": "f4236c4c-8aa1-4395-9c80-e66b96ed7104",
                "nextId": "b711e3a3-219a-44c0-85f1-076b9d68bcda"
              },
              {
                "id": "b711e3a3-219a-44c0-85f1-076b9d68bcda",
                "identifier": "3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "1433f629-261d-4190-ad29-c17d0a5246eb",
                "instanceType": "EligibilityCriterion",
                "name": "Prior Pneumococcal Vaccine",
                "previousId": "b80d0e8c-1540-473a-be7c-b750b745526d",
                "nextId": "02aabed9-83d2-42e4-a8b7-e1d7e791fed7"
              },
              {
                "id": "02aabed9-83d2-42e4-a8b7-e1d7e791fed7",
                "identifier": "4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "28b79fc7-44cb-4c8a-a5ac-3a1d3d82c063",
                "instanceType": "EligibilityCriterion",
                "name": "Severe Allergic Reaction",
                "previousId": "b711e3a3-219a-44c0-85f1-076b9d68bcda",
                "nextId": "01c65327-d5ad-4911-82bc-3e2c1f5f5da8"
              },
              {
                "id": "01c65327-d5ad-4911-82bc-3e2c1f5f5da8",
                "identifier": "5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "186ff9f8-45b9-47f5-989e-37f8aab684e9",
                "instanceType": "EligibilityCriterion",
                "name": "Serious Chronic Disorder",
                "previousId": "02aabed9-83d2-42e4-a8b7-e1d7e791fed7",
                "nextId": "336b5f3c-d238-4f86-920e-4d52a4b30fbf"
              },
              {
                "id": "336b5f3c-d238-4f86-920e-4d52a4b30fbf",
                "identifier": "6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b5c965f6-e14f-442f-b30a-eabad6933983",
                "instanceType": "EligibilityCriterion",
                "name": "Acute or Psychiatric Condition",
                "previousId": "01c65327-d5ad-4911-82bc-3e2c1f5f5da8",
                "nextId": "0902cc30-788a-4cd8-b873-845435f52e23"
              },
              {
                "id": "0902cc30-788a-4cd8-b873-845435f52e23",
                "identifier": "7",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c7653338-be5f-4664-9114-a6e28f52c290",
                "instanceType": "EligibilityCriterion",
                "name": "Invasive S. pneumoniae Disease",
                "previousId": "336b5f3c-d238-4f86-920e-4d52a4b30fbf",
                "nextId": "9802745a-75fc-48ce-969d-ba2327520847"
              },
              {
                "id": "9802745a-75fc-48ce-969d-ba2327520847",
                "identifier": "8",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "3b7215c0-39ee-4c2b-b2a6-bf09810d89b6",
                "instanceType": "EligibilityCriterion",
                "name": "Immunosuppressive Therapy",
                "previousId": "0902cc30-788a-4cd8-b873-845435f52e23",
                "nextId": "50a8a873-7159-4764-9c71-2d912383c20b"
              },
              {
                "id": "50a8a873-7159-4764-9c71-2d912383c20b",
                "identifier": "9",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0b40016c-d53d-46af-a794-b1f646f69443",
                "instanceType": "EligibilityCriterion",
                "name": "Immunodeficiency",
                "previousId": "9802745a-75fc-48ce-969d-ba2327520847",
                "nextId": "029f78a0-6cd4-4942-8a1e-05a5bb397655"
              },
              {
                "id": "029f78a0-6cd4-4942-8a1e-05a5bb397655",
                "identifier": "10",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "107097c2-59e4-4a79-8207-d7003b5da457",
                "instanceType": "EligibilityCriterion",
                "name": "Bleeding Diathesis",
                "previousId": "50a8a873-7159-4764-9c71-2d912383c20b",
                "nextId": "e85a441d-de7a-47e7-a2f9-976c3baa77b3"
              },
              {
                "id": "e85a441d-de7a-47e7-a2f9-976c3baa77b3",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "99c028a9-c10e-4589-8f65-c452e7e5b0d1",
                "instanceType": "EligibilityCriterion",
                "name": "Blood Products",
                "previousId": "029f78a0-6cd4-4942-8a1e-05a5bb397655",
                "nextId": "b2282011-8fdb-445d-b756-d2a1a7a7d771"
              },
              {
                "id": "b2282011-8fdb-445d-b756-d2a1a7a7d771",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c18add5c-5661-4438-bdfb-31b5347319b6",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy or Breastfeeding",
                "previousId": "e85a441d-de7a-47e7-a2f9-976c3baa77b3"
              }
            ],
            "population": {
              "id": "30443181-5f5f-4717-b6bf-2041e03060a9",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "15310072-243a-4803-9125-04813c6cb600",
                "675ac8bd-01b8-4c70-a873-866c3c4c8912",
                "2f6d4c00-da15-4c6a-87d1-3c0dd28a6c5c",
                "7d34f3da-2abc-4fa4-9f9f-52ceb77610c4",
                "f0a6abf2-3275-4773-9dc4-e5195a12a4b2",
                "5700e394-fbf8-47ed-864e-9926ac1a86ab",
                "f4236c4c-8aa1-4395-9c80-e66b96ed7104",
                "b80d0e8c-1540-473a-be7c-b750b745526d",
                "b711e3a3-219a-44c0-85f1-076b9d68bcda",
                "02aabed9-83d2-42e4-a8b7-e1d7e791fed7",
                "01c65327-d5ad-4911-82bc-3e2c1f5f5da8",
                "336b5f3c-d238-4f86-920e-4d52a4b30fbf",
                "0902cc30-788a-4cd8-b873-845435f52e23",
                "9802745a-75fc-48ce-969d-ba2327520847",
                "50a8a873-7159-4764-9c71-2d912383c20b",
                "029f78a0-6cd4-4942-8a1e-05a5bb397655",
                "e85a441d-de7a-47e7-a2f9-976c3baa77b3",
                "b2282011-8fdb-445d-b756-d2a1a7a7d771"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "0dc15cc4-7deb-4104-a2cc-86704c78cf1a",
                "name": "Primary Safety Objective (All Cohorts)",
                "text": "To describe the safety profile of 20vPnC in adults 18 years of age and older.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "61c9fd9f-98f2-422a-ade9-76550e797a05",
                  "8c3d9be2-31e7-4f1a-8ca9-6a874d39b581",
                  "a37af72c-f2a2-4a1e-b332-2624edbc8363",
                  "8c340b91-e576-4d5f-ab08-bd3a962d6dec"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "970276ef-847a-4990-8c90-313f0664513b",
                "name": "Primary Immunogenicity Objective 1 - Cohort 1",
                "text": "To demonstrate that the immune responses to the 13 serotypes in 13vPnC (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) induced by 20vPnC in adults 60 years of age and older are noninferior to the immune response induced by 13vPnC.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "d1b756b7-2135-4654-b283-2511387bb38a"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "82809c63-eef3-4469-b6ee-16f7e4769967",
                "name": "Primary Immunogenicity Objective 2 - Cohort 1",
                "text": "To demonstrate that the immune responses to the 7 additional serotypes (8, 10A, 11A, 12F, 15B, 22F, and 33F) induced by 20vPnC in adults 60 years of age and older are noninferior to the immune response induced by PPSV23.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "d1b756b7-2135-4654-b283-2511387bb38a"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "a8f84129-a0aa-4c34-9428-626cda90eca6",
                "name": "Secondary Objective - Cohort 2",
                "text": "To demonstrate that the immune responses to the 20 serotypes in 20vPnC induced in adults 50 through 59 years of age are noninferior to the immune responses induced by 20vPnC in adults 60 through 64 years of age.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "2fbef8e8-b111-431b-bb1d-2ef8f9f53355"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "d7f0ca6c-b79b-4306-ac23-86df5b9917c9",
                "name": "Secondary Objective - Cohort 3",
                "text": "To demonstrate that the immune responses to the 20 serotypes in 20vPnC induced in adults 18 through 49 years of age are noninferior to the immune responses induced by 20vPnC in adults 60 through 64 years of age.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "b1f3e7d0-2eec-46e6-8b87-8e14a8fdb367"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "86b76736-a2bc-4f26-8d33-2c426bb91cc9",
                "name": "Secondary Objective - All Cohorts",
                "text": "To describe the immune responses to 20vPnC in adults 60 years of age and older, 50 through 59 years of age, and 18 through 49 years of age.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "6f2e7b36-4e5f-4ddb-aa2b-b03e2b25cf4a",
                  "625f5f0c-d601-4c2a-9699-04ac27d25e8b",
                  "c4a7be72-e19a-4f5d-be15-a1b379d05a13"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "61c9fd9f-98f2-422a-ade9-76550e797a05",
                "name": "Prompted Local Reactions",
                "text": "Reported prompted local reactions (redness, swelling, and pain at the injection site) within 10 days after vaccination.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "8c3d9be2-31e7-4f1a-8ca9-6a874d39b581",
                "name": "Prompted Systemic Events",
                "text": "Reported prompted systemic events (fever, headache, fatigue, muscle pain, and joint pain) within 7 days after vaccination.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "a37af72c-f2a2-4a1e-b332-2624edbc8363",
                "name": "Adverse Events",
                "text": "Reported adverse events (AEs) within 1 month after vaccination.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "8c340b91-e576-4d5f-ab08-bd3a962d6dec",
                "name": "SAEs and NDCMCs",
                "text": "Reported serious adverse events (SAEs) and newly diagnosed chronic medical conditions (NDCMCs) within 6 months after vaccination.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "d1b756b7-2135-4654-b283-2511387bb38a",
                "name": "Primary Immunogenicity Endpoint - Cohort 1",
                "text": "Serotype-specific opsonophagocytic activity (OPA) titers 1 month after vaccination.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "2fbef8e8-b111-431b-bb1d-2ef8f9f53355",
                "name": "Secondary Endpoint - Cohort 2",
                "text": "Serotype-specific OPA titers 1 month after vaccination.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "b1f3e7d0-2eec-46e6-8b87-8e14a8fdb367",
                "name": "Secondary Endpoint - Cohort 3",
                "text": "Serotype-specific OPA titers 1 month after vaccination.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "6f2e7b36-4e5f-4ddb-aa2b-b03e2b25cf4a",
                "name": "OPA Fold Rise",
                "text": "Fold rise in serotype-specific OPA titers from before to 1 month after vaccination.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "625f5f0c-d601-4c2a-9699-04ac27d25e8b",
                "name": ">=4-Fold OPA Rise",
                "text": ">=4-Fold rise in serotype-specific OPA titers from before to 1 month after vaccination.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "c4a7be72-e19a-4f5d-be15-a1b379d05a13",
                "name": "OPA >=LLOQ",
                "text": "Serotype-specific OPA titers greater than or equal to the lower limit of quantitation (>=LLOQ) 1 month after vaccination.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              }
            ],
            "estimands": [
              {
                "id": "7c7d1e23-9e3f-4930-94a9-0526eccb35f8",
                "name": "Primary Immunogenicity Estimand - Cohort 1",
                "populationSummary": "Adults 60 years of age and older with no history of pneumococcal vaccination (Cohort 1) Summary measure: Geometric mean ratio (GMR).",
                "analysisPopulationId": "8cec8839-4842-4e63-aa1f-a5e464ca2a35",
                "variableOfInterestId": "d1b756b7-2135-4654-b283-2511387bb38a",
                "interventionIds": [
                  "2390bc79-654e-4106-b68d-d579502e4b80"
                ],
                "intercurrentEvents": [
                  {
                    "id": "6508748b-3187-49bb-b564-52e432a87ec8",
                    "name": "Protocol deviation",
                    "text": "Major protocol deviations affecting the immunogenicity assessment",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "2e799958-37ac-4328-b907-820a91547f3d",
                    "name": "Non-study vaccination",
                    "text": "Receipt of prohibited non-study pneumococcal vaccines",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "5261f076-6b37-4101-950d-00f9c95e21b1",
                    "name": "Withdrawal/Discontinuation",
                    "text": "Subject withdraws from study before the 1-month blood draw",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "20vPnC followed by Saline vs 13vPnC followed by PPSV23",
                "analysisPopulation": "Adults 60 years of age and older with no history of pneumococcal vaccination (Cohort 1)",
                "variableOfInterest": "Serotype-specific opsonophagocytic activity (OPA) titers 1 month after vaccination",
                "summaryMeasure": "Geometric mean ratio (GMR)"
              },
              {
                "id": "a3930035-de5d-47c1-ac77-cd429399b6e8",
                "name": "Primary Safety Estimand - Local Reactions",
                "populationSummary": "Adults 18 years of age and older (All Cohorts) Summary measure: Percentage of subjects.",
                "analysisPopulationId": "7c4cf061-6450-4436-8d08-56762091c9f9",
                "variableOfInterestId": "61c9fd9f-98f2-422a-ade9-76550e797a05",
                "interventionIds": [
                  "7bfa9d56-7dc5-40c4-ac21-d107494e8cf7"
                ],
                "intercurrentEvents": [
                  {
                    "id": "d06a3e30-ddff-440d-82c1-d91827b58654",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues study before the 10-day diary period is complete",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "20vPnC vs Control (13vPnC or Saline/PPSV23)",
                "analysisPopulation": "Adults 18 years of age and older (All Cohorts)",
                "variableOfInterest": "Reported prompted local reactions within 10 days",
                "summaryMeasure": "Percentage of subjects"
              },
              {
                "id": "40fdb655-17ae-44e6-a6a0-248ee50a6bab",
                "name": "Secondary Immunogenicity Estimand - Cohort 2",
                "populationSummary": "Adults 50 through 59 years of age (Cohort 2) compared to adults 60 through 64 years of age Summary measure: Geometric mean ratio (GMR).",
                "analysisPopulationId": "7559bc0f-422a-4b97-b176-b4335e8d90c8",
                "variableOfInterestId": "2fbef8e8-b111-431b-bb1d-2ef8f9f53355",
                "interventionIds": [
                  "4b36a31f-23d6-498e-89a1-9856e4076de3"
                ],
                "intercurrentEvents": [
                  {
                    "id": "fd8417e2-183d-4436-81af-5c3b8beb64fd",
                    "name": "Missing data",
                    "text": "Missing immunogenicity data at the 1-month visit",
                    "strategy": "Hypothetical",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "20vPnC in Cohort 2 vs 20vPnC in Cohort 1 (60-64 years)",
                "analysisPopulation": "Adults 50 through 59 years of age (Cohort 2) compared to adults 60 through 64 years of age",
                "variableOfInterest": "Serotype-specific OPA titers 1 month after vaccination",
                "summaryMeasure": "Geometric mean ratio (GMR)"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "9fc41c3f-3dca-418a-89be-62eab228ceb2",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "c4c18e9f-3268-42f9-90d0-e8032d1a13d8",
                "instances": [
                  {
                    "id": "c4c18e9f-3268-42f9-90d0-e8032d1a13d8",
                    "activityIds": [
                      "860f4fac-4947-42c7-baf6-34539dfe1394"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "9e7d302a-a9e9-433a-9558-a8c7620e67e7",
                    "activityIds": [
                      "860f4fac-4947-42c7-baf6-34539dfe1394"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_2",
                    "encounterId": "5d8cd305-349c-49c4-b255-9b1b74507373",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "bcfd3052-19ba-4c75-a886-4ad63e215f8d",
                    "activityIds": [
                      "860f4fac-4947-42c7-baf6-34539dfe1394"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_4",
                    "encounterId": "1631e1fd-322a-4869-8572-a06a8b009b42",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "60e09f7a-126d-4497-90fe-dee2627bf053",
                    "activityIds": [
                      "860f4fac-4947-42c7-baf6-34539dfe1394"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_5",
                    "encounterId": "95d12b86-598f-4810-8015-5a5e875738c5",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "bac8f3a9-6f3e-4add-9f12-e3e628cde2ac",
                    "activityIds": [
                      "16ce974f-90c7-4a8e-8bcf-c79b552be002"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "3fa70770-826e-41a7-afed-f5df9ac38e78",
                    "activityIds": [
                      "16ce974f-90c7-4a8e-8bcf-c79b552be002"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_2",
                    "encounterId": "5d8cd305-349c-49c4-b255-9b1b74507373",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "d13782d3-e42f-4a0a-b377-d803adfe7ba7",
                    "activityIds": [
                      "16ce974f-90c7-4a8e-8bcf-c79b552be002"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_4",
                    "encounterId": "1631e1fd-322a-4869-8572-a06a8b009b42",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "671ebaae-0933-484a-bd08-0c67416e2791",
                    "activityIds": [
                      "16ce974f-90c7-4a8e-8bcf-c79b552be002"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_5",
                    "encounterId": "95d12b86-598f-4810-8015-5a5e875738c5",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "457058ee-620b-476b-a8d2-c8418c52acc4",
                    "activityIds": [
                      "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "a0733898-8a7a-40d3-912f-b0fb2c9249e6",
                    "activityIds": [
                      "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_2",
                    "encounterId": "5d8cd305-349c-49c4-b255-9b1b74507373",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "c7aaa0ce-8cfa-41fb-83a4-5809520bb313",
                    "activityIds": [
                      "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_3",
                    "encounterId": "105a3bd0-ccc7-4396-a805-529ade17bb34",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "802052a8-c68d-4bfe-880d-e24fb9b68d80",
                    "activityIds": [
                      "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_4",
                    "encounterId": "1631e1fd-322a-4869-8572-a06a8b009b42",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "fd477c3f-d223-42bc-8310-20da2a9cc825",
                    "activityIds": [
                      "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_5",
                    "encounterId": "95d12b86-598f-4810-8015-5a5e875738c5",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "111b1c38-fdf5-4ebd-9de4-4de609f31e83",
                    "activityIds": [
                      "bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "70380e34-5d39-48a0-8cf1-28821b9647d2",
                    "activityIds": [
                      "bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_2",
                    "encounterId": "5d8cd305-349c-49c4-b255-9b1b74507373",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "9b9f9bdf-498d-4c34-82a8-9ad20d8b5199",
                    "activityIds": [
                      "bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_4",
                    "encounterId": "1631e1fd-322a-4869-8572-a06a8b009b42",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "b8bd0889-9599-4eb9-93ea-a37c0f6cae9c",
                    "activityIds": [
                      "dea159e9-f1c0-4ba7-8636-7e2b4ba8db96"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "8062ff78-2cd9-41b5-949c-4c326f4f77d0",
                    "activityIds": [
                      "dea159e9-f1c0-4ba7-8636-7e2b4ba8db96"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_3",
                    "encounterId": "105a3bd0-ccc7-4396-a805-529ade17bb34",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "b9258b86-8ce7-47db-9192-e505b24a2f15",
                    "activityIds": [
                      "dea159e9-f1c0-4ba7-8636-7e2b4ba8db96"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_4",
                    "encounterId": "1631e1fd-322a-4869-8572-a06a8b009b42",
                    "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12"
                  },
                  {
                    "id": "9f9684e7-c54f-412f-a048-2f8bba902483",
                    "name": "InformedConsent",
                    "description": "Event anchor: InformedConsent",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "41107c83-32f8-46db-a6ca-e72699fc74c4",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "ac81266a-3857-42f2-97ba-7bfbec1850b5",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 10
                      }
                    ],
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                    "scheduledDay": 1
                  },
                  {
                    "id": "4baf6890-33fa-4996-acea-63b965860afa",
                    "name": "Day1",
                    "description": "Visit anchor: Day1",
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "41107c83-32f8-46db-a6ca-e72699fc74c4",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "ac81266a-3857-42f2-97ba-7bfbec1850b5",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 80
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "6a302322-681f-4216-a099-df22ec1f73b6",
                    "name": "Anchor: Cohort 1 Visit 2 Window",
                    "activityIds": [],
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "de819239-9a6d-4f96-aaeb-99743acbaf0c",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "bcc18818-27ba-4d7f-b221-01e7a2c58d31",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "117c1dd4-ed59-4525-b567-089787935160",
                    "name": "Anchor: Cohort 1 Visit 3 Window",
                    "activityIds": [],
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "575f46b4-9db5-4758-80cd-35eccaf2fd71",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "59ce7f2d-9cbb-44c1-b69a-81468537ae35",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "754a59b3-0ac0-4a35-a6ee-d64cfce674a5",
                    "name": "Anchor: Cohorts 2 and 3 Visit 2 Window",
                    "activityIds": [],
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "051fcc2a-f17d-4736-81bf-12e406ca3b0f",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "33140aef-0400-4ed7-bcbb-f93cf0915562",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  },
                  {
                    "id": "e4610b3f-063c-4742-8fc5-ecf2a15b2705",
                    "name": "Anchor: Final Safety Visit (All Cohorts)",
                    "activityIds": [],
                    "encounterId": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "f2012ae9-1363-456f-a136-2e9d977ec2a8",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "4169d658-24bc-4d55-8b9e-60b251280a34",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94"
                  }
                ],
                "timings": [
                  {
                    "id": "6ec14ad9-f2c0-44fb-bfe1-27a6ccbfcb95",
                    "name": "Cohort 1 Visit 2 Window",
                    "type": {
                      "id": "5dc4edfb-176c-41bc-813a-ef825c397413",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "f58be518-61d9-42b9-a79a-5cf5248493d2",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "6a302322-681f-4216-a099-df22ec1f73b6",
                    "instanceType": "Timing",
                    "windowLower": "P28D",
                    "windowUpper": "P42D"
                  },
                  {
                    "id": "748d37ff-e743-4e8c-801c-400591e80ed6",
                    "name": "Cohort 1 Visit 3 Window",
                    "type": {
                      "id": "a63d3be6-d8e5-4c2f-90ee-2dd751220a8c",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "c005acff-2d28-4c04-b991-ce7c43742cb7",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "117c1dd4-ed59-4525-b567-089787935160",
                    "instanceType": "Timing",
                    "windowLower": "P28D",
                    "windowUpper": "P42D"
                  },
                  {
                    "id": "933b8da9-91cf-4508-9efe-446cc6f9b8e7",
                    "name": "Cohorts 2 and 3 Visit 2 Window",
                    "type": {
                      "id": "1b375261-057c-4483-8331-ca3fc8c2e117",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "5fd5dd71-5e0c-4cc1-9cb7-012a7a7d63ac",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "754a59b3-0ac0-4a35-a6ee-d64cfce674a5",
                    "instanceType": "Timing",
                    "windowLower": "P28D",
                    "windowUpper": "P42D"
                  },
                  {
                    "id": "96a13462-9e97-4b32-9ee7-fe2d3d1bc725",
                    "name": "Final Safety Visit (All Cohorts)",
                    "type": {
                      "id": "d5edcf47-305e-4574-b560-93b702551f89",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P168D",
                    "valueLabel": "Day 168",
                    "relativeToFrom": {
                      "id": "e98ad1fb-0ab0-4925-a36c-146613efdcfa",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "e4610b3f-063c-4742-8fc5-ecf2a15b2705",
                    "instanceType": "Timing",
                    "windowLower": "P168D",
                    "windowUpper": "P196D"
                  },
                  {
                    "id": "eabeb0b6-0dc4-4898-9055-e31eb8de3a5a",
                    "name": "Observation Period",
                    "type": {
                      "id": "84d4d5a2-5c65-4856-8c19-36d656a61136",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "PT30M",
                    "valueLabel": "30 minutes",
                    "relativeToFrom": {
                      "id": "ff3a8ca8-d02d-4119-bcba-731ebcf72a5f",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "25f9cfcc-4967-4e0d-8024-360b5e58d801",
                    "instanceType": "Timing",
                    "windowLower": "PT30M",
                    "windowUpper": "PT60M"
                  },
                  {
                    "id": "d8488298-ab0b-488e-9aad-500470c626f9",
                    "name": "Local Reaction Collection",
                    "type": {
                      "id": "f7e4a7a4-d80c-422c-9bd5-ac720025cbdb",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P10D",
                    "valueLabel": "Day 10",
                    "relativeToFrom": {
                      "id": "33ee3588-4774-4880-991f-047271f008a6",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "90688efb-e077-4573-8ee2-29edb9437f96",
                    "instanceType": "Timing",
                    "windowLower": "P0D",
                    "windowUpper": "P10D"
                  },
                  {
                    "id": "34725d26-0351-4f85-933a-5d037c7b95c7",
                    "name": "Systemic Event Collection",
                    "type": {
                      "id": "54a5be10-4386-48e6-a7ac-df0582847ed7",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P7D",
                    "valueLabel": "Day 7",
                    "relativeToFrom": {
                      "id": "f1c83cc6-dd5e-4b37-a21b-da5e0fe273ea",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "665c70f1-477f-4766-b89c-43e721deea03",
                    "instanceType": "Timing",
                    "windowLower": "P0D",
                    "windowUpper": "P7D"
                  }
                ],
                "exits": [
                  {
                    "id": "b49b2369-3fdc-4f81-820b-12120dddd5d9",
                    "name": "Subject Withdrawal",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Subjects may withdraw at any time at their own request or investigator discretion."
                  },
                  {
                    "id": "1f184061-00ad-4aec-a72d-4a35d7ebba52",
                    "name": "Lost to Follow-up",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Inability to reach subject after 2 phone calls/emails and 1 registered mail letter."
                  },
                  {
                    "id": "3aa54aa9-fc93-42aa-ba4b-66a83add0375",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Completion of the 6-month safety follow-up telephone contact."
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "5d8cd305-349c-49c4-b255-9b1b74507373",
                "name": "Cohort 1 Control (13vPnC)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b0588f76-c22c-46d1-8a30-71520fc7e957",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "extensionAttributes": [
                  {
                    "id": "f038c4f5-3507-4d39-ae3e-b1207c8ffe3b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9f22c93f-3ba1-49bf-8701-8bda92d59014",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "105a3bd0-ccc7-4396-a805-529ade17bb34",
                "name": "Cohort 1 Control (PPSV23)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ad1168fd-e3e1-4b49-9254-c48d3461cfa0",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "extensionAttributes": [
                  {
                    "id": "992f1381-d887-435f-8508-8efeb5a796a9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "72cc366d-c534-441a-bd5b-223287d2304b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "b08a054d-8a8e-4a5b-b7da-0eb789a9db27",
                "name": "Cohort 1 Investigational (20vPnC)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b93be7d9-1c57-4108-bfde-205d65327b7c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "extensionAttributes": [
                  {
                    "id": "28254adf-10c1-4b05-891f-40c60a7092e8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e36eceae-7a36-4448-8e2f-8ee2946ea6bc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "95d12b86-598f-4810-8015-5a5e875738c5",
                "name": "Cohort 2/3 Control (13vPnC)",
                "instanceType": "Encounter",
                "type": {
                  "id": "650f966f-c3e2-4e7f-9ee2-a3e7b48f1b14",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "extensionAttributes": [
                  {
                    "id": "0c9751f6-e9d1-4583-8980-2ebd7e626915",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c30dec6f-9173-40c3-af8f-dedcbbfae6f9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "1631e1fd-322a-4869-8572-a06a8b009b42",
                "name": "Cohort 2/3 Investigational (20vPnC)",
                "instanceType": "Encounter",
                "type": {
                  "id": "30098ecf-e560-4ab6-b716-98313f0dd98b",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "extensionAttributes": [
                  {
                    "id": "78d50115-7c7c-42a5-b496-41a221eb10d6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e1a7feed-f813-4619-a31c-bca33c6e0b1a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388",
                "name": "Adverse events",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c5d0a92a-4396-47e8-93a4-8b705f4057e9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d15e0c9a-53ab-4c91-ad60-edc00069514f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c663f663-eba0-48bb-95c7-b44f2730a85e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f465e470-3500-4cdd-92a0-173fccdd3d2d",
                "name": "Anthropometric Measurements",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "f465e470-3500-4cdd-92a0-173fccdd3d2d",
                    "name": "Anthropometric Measurements",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "3b4e260d-2a46-46df-8945-2fee0d2a86db",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Height and Weight",
                    "description": "Measurement of subject height and weight."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "822396f3-e767-462a-97cf-cb397777d192",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "741b7221-f2b8-45fe-ac80-d8017cdbf0e4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2d5c6601-6931-4f52-8449-7a8eca3e4d09",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "51d35808-acd2-4d6e-8a88-db5d84ee0717",
                "name": "Clinical Assessment",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "51d35808-acd2-4d6e-8a88-db5d84ee0717",
                    "name": "Clinical Assessment",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "de378157-76c4-4710-b6c3-7a56ab48eb70",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Clinical Assessment",
                    "description": "Assessment including medical history, smoking history, and physical examination if necessary."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b0db533d-6d30-49f2-9a83-9869032874cc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "92edfb17-5a78-4a88-bc0a-52471b3d31d8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "87580207-4806-4b1d-bb1e-418c8944ea0d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f",
                "name": "Immune responses to the 13vPnC serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e8f6bbec-034d-4eb7-ab7e-69a24c4fb744",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9a6c598e-2821-4e80-ba8e-1c38e08cd8c4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "2249d173-a612-4713-b56c-d0479c1b0425",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "dea159e9-f1c0-4ba7-8636-7e2b4ba8db96",
                "name": "Immune responses to the additional 7 serotypes: 8, 10A, 11A, 12F, 15B, 22F, 33F",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "765f5fde-d784-48dc-a36d-dcc59a054c2c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "81107b3a-bd0e-4b20-8753-46fff9463366",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "db9a505a-30e7-42f5-96f8-0f20faaa2127",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "fd91cff3-1fc4-436b-81fe-3c9a412823f0",
                "name": "Informed Consent",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "fd91cff3-1fc4-436b-81fe-3c9a412823f0",
                    "name": "Informed Consent",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "93b7a429-6a62-4186-b3e3-723daf6ac9fc",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Obtain Informed Consent",
                    "description": "Obtaining written informed consent before performing any study-specific procedures."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7aeecb72-4c83-43d2-9d65-4d7b04a5e83e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "2c8f4dfb-0592-4f66-bbf5-d3d23599fa7c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "87fb0f31-5d37-4c11-8f0c-5b2e6afece7d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9411937d-c50b-4c29-a75b-63907a067ed3",
                "name": "Intramuscular Injection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "9411937d-c50b-4c29-a75b-63907a067ed3",
                    "name": "Intramuscular Injection",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "b37c1510-cf0b-487f-84c0-2f3cf42db43e",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vaccine Administration",
                    "description": "Administration of 0.5-mL dose of investigational product into the deltoid muscle."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2cff0858-832a-47e3-8aaf-f94fcce84702",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "2d74bc4d-2b95-40ca-bf74-21941e16bb87",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "228805ca-4139-423d-a662-4af4ebc7cff5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "30106400-5a14-457c-807b-aca7b733c327",
                "name": "Post-Vaccination Observation",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "30106400-5a14-457c-807b-aca7b733c327",
                    "name": "Post-Vaccination Observation",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "58ad2613-7067-435e-842b-bb53c456fc00",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Acute Reaction Monitoring",
                    "description": "Observation for at least 30 minutes after administration for acute reactions."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b15045a2-b144-4ac6-bb99-f304d8b9affc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "1f41e0ee-7997-46ab-bc23-078e3e83f40c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "d0caa108-7683-4086-a29e-8b996a3c5ef6",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "860f4fac-4947-42c7-baf6-34539dfe1394",
                "name": "Prompted local reactions",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "933e9b61-941e-4b7e-b382-447d7ed34f93",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6b0d10ca-a671-4ee0-ae24-8809d6a073f5",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0a153917-7a5c-4504-8be9-6b8287c1fa5e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "16ce974f-90c7-4a8e-8bcf-c79b552be002",
                "name": "Prompted systemic events",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "0d5a928b-d613-450f-9dcc-35ed92c2cb15",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b3e8eccd-f4d3-404a-af47-ed2cb211bef2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6636959d-4189-44df-904f-d4506edbbcaf",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e3b979e0-35d7-4d7d-969b-166c9aa6da2b",
                "name": "Telephone Follow-up",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e3b979e0-35d7-4d7d-969b-166c9aa6da2b",
                    "name": "Telephone Follow-up",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "32c9d70b-a97b-44bc-b62b-04ba7066d682",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "6-Month Safety Collection",
                    "description": "Telephone contact to inquire about SAEs, NDCMCs, and nonstudy vaccinations."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c382ea49-9f5f-44cc-ad16-03d9520e994a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "b346717a-e81e-4c56-80ee-01e9e5d319a4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "0258cba7-1c9e-4b78-9865-b1631d097f2d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "1bbc71ba-9786-4677-bc66-ac61c84af6c3",
                "name": "Venipuncture",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "1bbc71ba-9786-4677-bc66-ac61c84af6c3",
                    "name": "Venipuncture",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "40eb3ab1-92c8-4c9f-92ff-5c504201d172",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Immunogenicity Blood Draw",
                    "description": "Collection of approximately 50 mL blood sample for immunogenicity assessments."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7657324a-b8c5-4b34-9b37-4f93cbe966ff",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "7b18e64c-373d-433e-98e9-104164f0940a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "de05ea90-de29-4be2-9597-b61248e46d3c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b2caeec3-f61c-4ff3-ad50-92324d97d583",
                "name": "Vital Signs Measurement",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "b2caeec3-f61c-4ff3-ad50-92324d97d583",
                    "name": "Vital Signs Measurement",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "16ee9c1c-068a-4548-82be-7c673ac09f63",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Oral Temperature",
                    "description": "Measurement of prevaccination oral temperature."
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "af39b004-f3db-48bf-92ed-21052174d71d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "ddb8037d-10ca-41da-b20d-c0205cc682ff",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "03ba77f5-9584-4a57-ba5b-9d422480f741",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "ec70db9b-a46d-48c4-96e4-ded4b973ce94",
                "name": "Cohort 1",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "594f1854-ec5b-498a-a38b-cf1ba933ef79",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "e00d93aa-7f4e-4651-96d3-eac6494d297a",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "7761757c-1424-4fd2-b0be-7dfade60068c",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "d82cf1ab-86ce-4364-ae86-d5852382aef2",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "7a0664fa-5e89-40ea-9730-9f54010b1a12",
                "name": "Cohort 2 and Cohort 3",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "03fd55d4-0c1e-4490-b2bd-0cface71510c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "f9bdae5d-a5b6-425c-bfc0-77b59d0d4c66",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e048e7fa-6991-4865-8588-7ea2068b0910",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "1eec132a-fdd9-469d-b9bd-59cc8899592d",
                "name": "Safety and Immunogenicity Assessments",
                "description": null,
                "childIds": [
                  "860f4fac-4947-42c7-baf6-34539dfe1394",
                  "16ce974f-90c7-4a8e-8bcf-c79b552be002",
                  "4d84ceb1-528f-4b82-aeb2-9ee8f40b2388",
                  "bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f",
                  "dea159e9-f1c0-4ba7-8636-7e2b4ba8db96"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Prompted local reactions",
                  "Prompted systemic events",
                  "Adverse events",
                  "Immune responses to the 13vPnC serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F",
                  "Immune responses to the additional 7 serotypes: 8, 10A, 11A, 12F, 15B, 22F, 33F"
                ]
              }
            ],
            "notes": [
              {
                "id": "2ed6d61e-9b20-4fb7-b648-414dccb35d9f",
                "text": "a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV23 at Visit 2.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "3e56fb16-19a6-4d9a-bb61-b04b110865a8",
                "text": "b. Control group after vaccination with PPSV23 at Visit 2.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "6b25972a-c542-44ce-b79a-091c4906b878",
                "text": "c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months after Visit 1.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "e1f1a833-3f3d-4719-a380-4419e9a2fec9",
                "text": "b. Control group after vaccination with PPSV23 at Visit 2.",
                "instanceType": "Note"
              },
              {
                "id": "7f5324c9-68c8-477b-8ca8-575faeaafcf4",
                "text": "c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months after Visit 1.",
                "instanceType": "Note"
              },
              {
                "id": "4083e11f-d36c-411c-97ce-11666dbf197c",
                "text": "4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects are enrolled. The following eligibility criteria are designed to select subjects for whom participation in the study is considered appropriate. All relevant medical and nonmedical conditions should be taken into consideration when deciding whether a particular subject is suitable for this protocol. Subject eligibility should be reviewed and documented by an appropriate member of the investigators ",
                "instanceType": "Note"
              },
              {
                "id": "2c1a7813-aadf-45aa-acf5-7e08356edfec",
                "text": "1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.",
                "instanceType": "Note"
              },
              {
                "id": "2a7509b2-698d-4167-9b2a-f730971c126f",
                "text": "2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures.",
                "instanceType": "Note"
              },
              {
                "id": "9e6c3558-c1e6-492f-bbd5-9cdf3f2d41ab",
                "text": "3. Expected to be available for the duration of the study and can be contacted by telephone during study participation.",
                "instanceType": "Note"
              },
              {
                "id": "9a64dc13-71bf-4547-bcbd-c9e22ebe6335",
                "text": "5. Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease,",
                "instanceType": "Note"
              },
              {
                "id": "1267fa81-a4e1-49d2-83f9-339a4e99770e",
                "text": "6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father children; male subject who is able to father children and willing to use a highly effective method of contraception as outlined in this protocol until at least 28 days after the last dose of investigational product. Cohorts 2 and 3 only: Female subject of childbearing potential or male subject who is able to father children, and willing to use a highly effective method of contraception as outlined in",
                "instanceType": "Note"
              },
              {
                "id": "24dad4e7-9f47-44e0-b471-06adec948e89",
                "text": "7. History of microbiologically proven invasive disease caused by S pneumoniae.",
                "instanceType": "Note"
              },
              {
                "id": "de64cfb6-8343-43a2-8c9b-9205ba705f38",
                "text": "9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppression, including, but not limited to, immunoglobulin class/subclass deficiencies, generalized malignancy, human immunodeficiency virus (HIV) infection, leukemia, lymphoma, or organ or bone marrow transplant.",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "96e22e9e-154e-4139-a788-daa000d73460",
              "code": "C82639",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Parallel Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "91fdac80-48d1-483b-a017-b59062f371f1",
                "name": "Pneumococcal infection",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Pneumococcal vaccinenave adults 18 years of age and older"
              }
            ],
            "procedures": [
              {
                "id": "fd91cff3-1fc4-436b-81fe-3c9a412823f0",
                "name": "Informed Consent",
                "procedureType": "Assessment",
                "code": {
                  "id": "93b7a429-6a62-4186-b3e3-723daf6ac9fc",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Obtain Informed Consent",
                "description": "Obtaining written informed consent before performing any study-specific procedures."
              },
              {
                "id": "51d35808-acd2-4d6e-8a88-db5d84ee0717",
                "name": "Clinical Assessment",
                "procedureType": "Assessment",
                "code": {
                  "id": "de378157-76c4-4710-b6c3-7a56ab48eb70",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Clinical Assessment",
                "description": "Assessment including medical history, smoking history, and physical examination if necessary."
              },
              {
                "id": "b2caeec3-f61c-4ff3-ad50-92324d97d583",
                "name": "Vital Signs Measurement",
                "procedureType": "Monitoring",
                "code": {
                  "id": "16ee9c1c-068a-4548-82be-7c673ac09f63",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Oral Temperature",
                "description": "Measurement of prevaccination oral temperature."
              },
              {
                "id": "f465e470-3500-4cdd-92a0-173fccdd3d2d",
                "name": "Anthropometric Measurements",
                "procedureType": "Assessment",
                "code": {
                  "id": "3b4e260d-2a46-46df-8945-2fee0d2a86db",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Height and Weight",
                "description": "Measurement of subject height and weight."
              },
              {
                "id": "1bbc71ba-9786-4677-bc66-ac61c84af6c3",
                "name": "Venipuncture",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "40eb3ab1-92c8-4c9f-92ff-5c504201d172",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Immunogenicity Blood Draw",
                "description": "Collection of approximately 50 mL blood sample for immunogenicity assessments."
              },
              {
                "id": "9411937d-c50b-4c29-a75b-63907a067ed3",
                "name": "Intramuscular Injection",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "b37c1510-cf0b-487f-84c0-2f3cf42db43e",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vaccine Administration",
                "description": "Administration of 0.5-mL dose of investigational product into the deltoid muscle."
              },
              {
                "id": "30106400-5a14-457c-807b-aca7b733c327",
                "name": "Post-Vaccination Observation",
                "procedureType": "Monitoring",
                "code": {
                  "id": "58ad2613-7067-435e-842b-bb53c456fc00",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Acute Reaction Monitoring",
                "description": "Observation for at least 30 minutes after administration for acute reactions."
              },
              {
                "id": "e3b979e0-35d7-4d7d-969b-166c9aa6da2b",
                "name": "Telephone Follow-up",
                "procedureType": "Monitoring",
                "code": {
                  "id": "32c9d70b-a97b-44bc-b62b-04ba7066d682",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "6-Month Safety Collection",
                "description": "Telephone contact to inquire about SAEs, NDCMCs, and nonstudy vaccinations."
              }
            ],
            "analysisPopulations": [
              {
                "id": "30443181-5f5f-4717-b6bf-2041e03060a9",
                "name": "Safety Analysis Population",
                "text": "The safety population will include any subject who: 1. receives 1 dose of any of the following: 20vPnC, 13vPnC, PPSV23, or saline; and 2. has safety follow-up after any vaccination.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "The safety population will include any subject who: 1. receives 1 dose of any of the following: 20vPnC, 13vPnC, PPSV23, or saline; and 2. has safety follow-up after any vaccination.",
                "criteria": "Received 1 dose of study vaccine/saline AND has safety follow-up"
              },
              {
                "id": "fc372735-0106-4461-8d8f-99fb4ba96516",
                "name": "Evaluable 13-Matched Immunogenicity Population  Cohort 1",
                "text": "Subjects in Cohort 1 who are included in the vaccine group as randomized and meet specific evaluability criteria for the 13 serotypes matched between 20vPnC and 13vPnC.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "Evaluable 13-Matched",
                "populationDescription": "Subjects in Cohort 1 who are included in the vaccine group as randomized and meet specific evaluability criteria for the 13 serotypes matched between 20vPnC and 13vPnC.",
                "criteria": "Cohort 1 AND randomized vaccine group AND met evaluability criteria for 13 matched serotypes"
              },
              {
                "id": "873513be-53a2-470d-94ee-6b394fbe57f8",
                "name": "Evaluable 7-Additional Immunogenicity Population  Cohort 1",
                "text": "Subjects in Cohort 1 who are included in the vaccine group as randomized and meet specific evaluability criteria for the 7 additional serotypes in 20vPnC compared to 13vPnC.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "Evaluable 7-Additional",
                "populationDescription": "Subjects in Cohort 1 who are included in the vaccine group as randomized and meet specific evaluability criteria for the 7 additional serotypes in 20vPnC compared to 13vPnC.",
                "criteria": "Cohort 1 AND randomized vaccine group AND met evaluability criteria for 7 additional serotypes"
              },
              {
                "id": "4d3e9ab0-f1b3-44cb-8a7b-36cca060be38",
                "name": "Evaluable Immunogenicity Population for Comparison of Cohorts 2 and 3 to Cohort 1",
                "text": "Subjects in Cohorts 2 and 3, and the comparison group in Cohort 1, who are included in the vaccine group as randomized and meet specific evaluability criteria for the 20 serotypes.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "Evaluable-20",
                "populationDescription": "Subjects in Cohorts 2 and 3, and the comparison group in Cohort 1, who are included in the vaccine group as randomized and meet specific evaluability criteria for the 20 serotypes.",
                "criteria": "Randomized vaccine group AND met evaluability criteria for 20 serotypes"
              }
            ],
            "characteristics": [
              {
                "id": "0521baaf-471b-4ffc-a0db-45c66e16d7ec",
                "code": "AGE",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Age",
                "instanceType": "Code"
              },
              {
                "id": "c5835fb0-8f45-4eea-aa6f-fe72d208923c",
                "code": "SEX",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Sex",
                "instanceType": "Code"
              },
              {
                "id": "d93ee3b4-806e-4f36-9e99-56b833506f5c",
                "code": "RACE",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Race",
                "instanceType": "Code"
              },
              {
                "id": "9d7b6aa2-c4c7-4b55-b158-dbd9e7dacd84",
                "code": "ETHNICITY",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Ethnicity",
                "instanceType": "Code"
              },
              {
                "id": "53b6b547-fb36-4a5c-9bec-56b3752a3b71",
                "code": "MEDICAL_HISTORY",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Medical History",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "ed01f561-3a3b-4400-85a4-1da1d700e7dc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"COHORT 1\": \"epoch_1\", \"COHORT_1\": \"epoch_1\", \"COHORT 2 AND COHORT 3\": \"epoch_2\", \"COHORT_2_AND_COHORT_3\": \"epoch_2\", \"VACCINATION_1\": \"epoch_1\"}, \"visitAliases\": {\"COHORT 1 INVESTIGATIONAL (20VPNC)\": \"enc_1\", \"COHORT_1_INVESTIGATIONAL_(20VPNC)\": \"enc_1\", \"COHORT 1 CONTROL (13VPNC)\": \"enc_2\", \"COHORT_1_CONTROL_(13VPNC)\": \"enc_2\", \"COHORT 1 CONTROL (PPSV23)\": \"enc_3\", \"COHORT_1_CONTROL_(PPSV23)\": \"enc_3\", \"COHORT 2/3 INVESTIGATIONAL (20VPNC)\": \"enc_4\", \"COHORT_2/3_INVESTIGATIONAL_(20VPNC)\": \"enc_4\", \"COHORT 2/3 CONTROL (13VPNC)\": \"enc_5\", \"COHORT_2/3_CONTROL_(13VPNC)\": \"enc_5\"}}"
              },
              {
                "id": "c2288b8a-d072-4d87-8309-2f2830324e26",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-classifiedIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'SCREENING' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"0a681b9c-1411-4ae0-9496-34028e2b2dc2\"], \"suggestion\": \"Create epoch for 'SCREENING' or map to existing epoch\"}, {\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'VACCINATION_2_OR_FOLLOW_UP' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"0a681b9c-1411-4ae0-9496-34028e2b2dc2\"], \"suggestion\": \"Create epoch for 'VACCINATION_2_OR_FOLLOW_UP' or map to existing epoch\"}, {\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'IMMUNOGENICITY_FOLLOW_UP' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"0a681b9c-1411-4ae0-9496-34028e2b2dc2\"], \"suggestion\": \"Create epoch for 'IMMUNOGENICITY_FOLLOW_UP' or map to existing epoch\"}, {\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'END_OF_STUDY_TELEPHONE_CONTACT' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"0a681b9c-1411-4ae0-9496-34028e2b2dc2\"], \"suggestion\": \"Create epoch for 'END_OF_STUDY_TELEPHONE_CONTACT' or map to existing epoch\"}]"
              },
              {
                "id": "ext_conceptual_99baba88-be9d-4b6a-9bbd-c42e7f000824",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"25f9cfcc-4967-4e0d-8024-360b5e58d801\", \"name\": \"Observation Period\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"90688efb-e077-4573-8ee2-29edb9437f96\", \"name\": \"Local Reaction Collection\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"665c70f1-477f-4766-b89c-43e721deea03\", \"name\": \"Systemic Event Collection\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "ffdeda52-df44-4b22-927e-921d6a3ab9af",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 6a302322-681f-4216-a099-df22ec1f73b6 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 117c1dd4-ed59-4525-b567-089787935160 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 754a59b3-0ac0-4a35-a6ee-d64cfce674a5 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: e4610b3f-063c-4742-8fc5-ecf2a15b2705 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Observation Period' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Local Reaction Collection' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Systemic Event Collection' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}]"
              },
              {
                "id": "096c9789-9e30-4dc6-8291-d554d883e499",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"0357a113-8128-4402-bc3a-49e64da7e4a0\", \"definition\": \"The day of the first vaccination (Vaccination 1)\", \"anchorType\": \"Day1\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 80, \"sourceText\": \"Visit Number 1, Visit Description Vaccination 1, Visit Window (Days) Day 1\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"229c9103-863e-4df9-829c-f2fb0743996b\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 10, \"sourceText\": \"informed consent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"e9e6af96-3ef6-45a8-9345-b9d854add030\", \"definition\": \"procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "91c84179-e179-4e3d-a65f-72f05f51ac25",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"c262d1c4-7971-4c52-979b-333ad2b6ea3a\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"4bb9d24b-5cb3-4a2e-95ec-e846155e53bc\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"OD\"}, {\"id\": \"c8343ecd-b1b4-461e-81e9-afdb338c1443\", \"type\": \"Continuous\", \"sourceText\": \"42 Days After\"}, {\"id\": \"d7c03c57-11c1-46ef-b8d8-c076978407dc\", \"type\": \"Continuous\", \"sourceText\": \"196 Days After\"}, {\"id\": \"a24800f9-8a0a-4ffd-9722-3bd379763289\", \"type\": \"Continuous\", \"sourceText\": \"7 days after\"}, {\"id\": \"72fb1c6e-786a-4167-92da-3598b3580127\", \"type\": \"Continuous\", \"sourceText\": \"10 days after\"}, {\"id\": \"5c6db31d-ed37-47b7-a888-560577e7a15d\", \"type\": \"Continuous\", \"sourceText\": \"42 days after\"}, {\"id\": \"f1d60db3-23b6-47e1-8500-10ffdc2a66ec\", \"type\": \"Continuous\", \"sourceText\": \"42 Days \\nAfter\"}, {\"id\": \"e722dbc2-fcc6-4cd7-a414-8648b1d4f18c\", \"type\": \"Continuous\", \"sourceText\": \"196 Days \\nAfter\"}, {\"id\": \"c5083d8f-83b9-409a-a3c1-5a312e1d0919\", \"type\": \"Continuous\", \"sourceText\": \"28 days after\"}, {\"id\": \"378fda08-6eaa-4148-850f-d42be15c2d5d\", \"type\": \"Continuous\", \"sourceText\": \"42 Days\\nAfter\"}, {\"id\": \"0f69240a-02ac-4f38-be11-3805b993782f\", \"type\": \"Continuous\", \"sourceText\": \"28 days before\"}, {\"id\": \"2c372c8d-b85f-43e9-96d7-0f7294c91fb3\", \"type\": \"Continuous\", \"sourceText\": \"60 days before\"}, {\"id\": \"5f72d130-1c6b-4a6c-a8a8-559262372e68\", \"type\": \"Continuous\", \"sourceText\": \"48 hours before\"}, {\"id\": \"1f67c13e-5b5b-4c72-9e50-2a8102744e53\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"endOffset\": \"P42D\", \"interval\": \"P28D\", \"minObservations\": 2, \"exitCondition\": \"Completion of Vaccination 2\", \"sourceText\": \"Cohort 1: Visit 2 (Vaccination 2 \\u2013 28 to 42 Days After Visit 1)\"}, {\"id\": \"889a2edb-51f8-4c5a-a36b-90341a28af90\", \"type\": \"Continuous\", \"startOffset\": \"P168D\", \"endOffset\": \"P196D\", \"interval\": \"P1D\", \"minObservations\": 1, \"exitCondition\": \"Completion of 6-Month Safety Collection\", \"sourceText\": \"6-Month Safety Collection [Telephone Contact] \\u2013 168 to 196 Days After Vaccination 1\"}, {\"id\": \"e2aac58a-4417-404d-9b20-1851d171cc2e\", \"type\": \"Daily\", \"startOffset\": \"P0D\", \"endOffset\": \"null\", \"interval\": \"P1D\", \"minObservations\": 7, \"exitCondition\": \"End of diary reporting period\", \"sourceText\": \"7.2.1. Subject Electronic Diary\"}]"
              },
              {
                "id": "f18929fc-d5c3-4aca-b0b3-0a7bb242a228",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"0a681b9c-1411-4ae0-9496-34028e2b2dc2\", \"requiredSequence\": [\"epoch_1\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [], \"sourceText\": \"[{'condition': 'Subject is in Cohort 1 (Age >= 60)', 'path': ['Visit 1 (Vaccination 1)', 'Visit 2 (Vaccination 2)', 'Visit 3 (Blood Draw)', 'Visit 4 (6-Month Follow-up)']}, {'condition': 'Subject is in Cohort 2 or 3 (Age 18-59)', 'path': ['Visit 1 (Vaccination 1)', 'Visit 2 (Blood Draw)', 'Visit 4 (6-Month Follow-up)']}]\"}]"
              },
              {
                "id": "f2e6e5c4-aeb0-4236-beb7-0101d3a78917",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"8209395d-4ea5-45b3-b983-e43f98314f83\", \"conditionType\": \"procedure_timepoints\", \"text\": \"a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV23 at Visit 2.\", \"footnoteId\": \"e655500b-403f-4aee-b480-46ee269d07f1\", \"structuredCondition\": \"group == 'Control' && time >= Visit1 && time < Visit2\", \"appliesToActivityIds\": [\"bdd6d3b5-599e-45ba-9068-8b4b0cb2ee2f\"], \"sourceText\": \"a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV2\"}, {\"id\": \"281d2d37-8e84-45f0-babe-eec2674ba4d7\", \"conditionType\": \"timing_after\", \"text\": \"b. Control group after vaccination with PPSV23 at Visit 2.\", \"footnoteId\": \"e78e2a9a-1e7c-4938-9602-2d5721149025\", \"structuredCondition\": \"group == 'Control' && time >= Visit2\", \"appliesToActivityIds\": [\"PPSV23 Vaccination\"], \"sourceText\": \"b. Control group after vaccination with PPSV23 at Visit 2.\"}, {\"id\": \"e1829c11-de7f-4fa4-8876-30f3f112aec1\", \"conditionType\": \"timing_after\", \"text\": \"c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months after Visit 1.\", \"footnoteId\": \"245467f9-3b61-4131-9aef-175f3659dcba\", \"structuredCondition\": \"collection.duration(SAE, NDCMC) <= P6M\", \"appliesToActivityIds\": [\"SAE Collection\", \"NDCMC Collection\"], \"sourceText\": \"c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months a\"}, {\"id\": \"5c4afbd1-ddbd-4032-bd70-1cacc0ce9a94\", \"conditionType\": \"timing_before\", \"text\": \"4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects are enrolled. The following eligibility criteria are designed to select subjects for whom participation in the study is considered appropriate. All relevant medical and nonmedical conditions should be taken into consideration when deciding whether a particular subject is suitable for this protocol. Subject eligibility should be reviewed and documented by an appropriate member of the investigator\\u2019s study team before subjects are included in the study.\", \"footnoteId\": \"c5033d7d-8e3b-40ba-ab02-2e77167a34ce\", \"structuredCondition\": \"eligibility.review_status == 'documented'\", \"appliesToActivityIds\": [\"Subject Enrollment\"], \"sourceText\": \"4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects a\"}, {\"id\": \"5539d932-1b0c-4495-8581-a0c41b25d553\", \"conditionType\": \"general\", \"text\": \"1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.\", \"footnoteId\": \"26456239-ad54-4db7-bd93-fd4ad5349a27\", \"structuredCondition\": \"subject.has_signed_icd == true\", \"appliesToActivityIds\": [\"Informed Consent\"], \"sourceText\": \"1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the sub\"}, {\"id\": \"c80a6946-826e-4c5f-bf7a-324b8d99457b\", \"conditionType\": \"general\", \"text\": \"2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures.\", \"footnoteId\": \"302a49fe-6814-4354-8af0-04bfb955e2fa\", \"structuredCondition\": \"subject.compliance_willingness == true\", \"appliesToActivityIds\": [\"All Study Procedures\"], \"sourceText\": \"2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures.\"}, {\"id\": \"cfddda6d-a7a8-48f0-9f52-d5fbd9efd200\", \"conditionType\": \"general\", \"text\": \"3. Expected to be available for the duration of the study and can be contacted by telephone during study participation.\", \"footnoteId\": \"124b3f54-12ce-4a28-aa72-c155ada0b466\", \"structuredCondition\": \"subject.availability == true && subject.phone_contactable == true\", \"appliesToActivityIds\": [\"All Study Procedures\"], \"sourceText\": \"3. Expected to be available for the duration of the study and can be contacted by telephone during s\"}, {\"id\": \"f9e51278-5f95-4d44-82f0-34f77e26bcf6\", \"conditionType\": \"general\", \"text\": \"5. Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease,\", \"footnoteId\": \"c74f34bf-66d4-422d-a12c-94d89fede7e7\", \"structuredCondition\": \"subject.age_group == 'Adult' && subject.disease_status == 'stable'\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"5. Adults determined by clinical assessment, including medical history and clinical judgment, to be \"}, {\"id\": \"5ac57b58-111e-4a1c-8029-3321ae3ff2e5\", \"conditionType\": \"timing_after\", \"text\": \"6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father children; male subject who is able to father children and willing to use a highly effective method of contraception as outlined in this protocol until at least 28 days after the last dose of investigational product. Cohorts 2 and 3 only: Female subject of childbearing potential or male subject who is able to father children, and willing to use a highly effective method of contraception as outlined in this protocol for at least 28 days after the last dose of investigational product; or female subject not of childbearing potential or male subject not able to father children.\", \"footnoteId\": \"f97dc83e-ce12-408f-b5c5-c521643d33ba\", \"structuredCondition\": \"(cohort == 1 && subject.fertility == false) || (cohort == 1 && subject.fertility == true && contraception.duration >= P28D) || (cohort.in([2,3]) && contraception.duration >= P28D)\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father chi\"}, {\"id\": \"1873eec3-6a64-4c58-8b62-39a84c3be7a1\", \"conditionType\": \"general\", \"text\": \"7. History of microbiologically proven invasive disease caused by S pneumoniae.\", \"footnoteId\": \"408e643a-f75a-41f0-b0f3-4416eda37988\", \"structuredCondition\": \"subject.history.invasive_s_pneumoniae == true\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"7. History of microbiologically proven invasive disease caused by S pneumoniae.\"}, {\"id\": \"51fa5930-c323-4c3f-af40-d9c5b8fae5f1\", \"conditionType\": \"timing_before\", \"text\": \"8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids, or planned receipt through the last blood draw. If systemic corticosteroids have been administered short term (<14 days) for treatment of an acute illness, subjects should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 28 days before investigational product administration. Inhaled/nebulized, intra-articular, intrabursal, or topical (skin or eyes) corticosteroids are permitted.\", \"footnoteId\": \"70bacd84-d044-46c2-b302-f04e38e7fb48\", \"structuredCondition\": \"subject.medication.immunosuppressive == false && (subject.medication.corticosteroids.short_term == true ? washout >= P28D : true)\", \"appliesToActivityIds\": [\"16ce974f-90c7-4a8e-8bcf-c79b552be002\"], \"sourceText\": \"8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or syst\"}, {\"id\": \"37701436-7e0a-404a-918d-db6adaf512ee\", \"conditionType\": \"general\", \"text\": \"9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppression, including, but not limited to, immunoglobulin class/subclass deficiencies, generalized malignancy, human immunodeficiency virus (HIV) infection, leukemia, lymphoma, or organ or bone marrow transplant.\", \"footnoteId\": \"20d7a33a-d30c-4a1e-b58a-99393a3c8309\", \"structuredCondition\": \"subject.immunodeficiency == false && subject.malignancy == false && subject.hiv == false\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppr\"}]"
              },
              {
                "id": "2304e416-26fd-4094-ab93-4c932d0bfe75",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"61c9fd9f-98f2-422a-ade9-76550e797a05\", \"name\": \"Primary Safety: Local Reactions\", \"endpointType\": \"Primary\", \"inputs\": [\"redness\", \"swelling\", \"pain at injection site\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P10D\"}, \"algorithm\": \"count(reported_prompted_local_reactions)\", \"successCriteria\": \"Descriptive safety profile\", \"sourceText\": \"Reported prompted local reactions (redness, swelling, and pain at the injection site) within 10 days after vaccination.\"}, {\"id\": \"8c3d9be2-31e7-4f1a-8ca9-6a874d39b581\", \"name\": \"Primary Safety: Systemic Events\", \"endpointType\": \"Primary\", \"inputs\": [\"fever\", \"headache\", \"fatigue\", \"muscle pain\", \"joint pain\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P7D\"}, \"algorithm\": \"count(reported_prompted_systemic_events)\", \"successCriteria\": \"Descriptive safety profile\", \"sourceText\": \"Reported prompted systemic events (fever, headache, fatigue, muscle pain, and joint pain) within 7 days after vaccination.\"}, {\"id\": \"a37af72c-f2a2-4a1e-b332-2624edbc8363\", \"name\": \"Primary Immunogenicity: OPA Titers (Cohort 1)\", \"endpointType\": \"Primary\", \"inputs\": [\"serotype-specific OPA titers\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P1M\"}, \"algorithm\": \"Geometric Mean Titers (GMTs) comparison (20vPnC vs 13vPnC/PPSV23)\", \"successCriteria\": \"Noninferiority to 13vPnC (13 serotypes) and PPSV23 (7 additional serotypes)\", \"sourceText\": \"Serotype-specific opsonophagocytic activity (OPA) titers 1 month after vaccination.\"}, {\"id\": \"8c340b91-e576-4d5f-ab08-bd3a962d6dec\", \"name\": \"Secondary Immunogenicity: OPA Titers (Cohort 2 & 3)\", \"endpointType\": \"Secondary\", \"inputs\": [\"serotype-specific OPA titers\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P1M\"}, \"algorithm\": \"Geometric Mean Titers (GMTs) comparison (Cohort 2/3 vs Cohort 60-64 years)\", \"successCriteria\": \"Noninferiority to immune responses induced by 20vPnC in adults 60 through 64 years of age\", \"sourceText\": \"Serotype-specific OPA titers 1 month after vaccination.\"}, {\"id\": \"d1b756b7-2135-4654-b283-2511387bb38a\", \"name\": \"Secondary Immunogenicity: OPA Fold Rise\", \"endpointType\": \"Secondary\", \"inputs\": [\"OPA_titer_baseline\", \"OPA_titer_post_vaccination\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P1M\"}, \"algorithm\": \"OPA_titer_post_vaccination / OPA_titer_baseline\", \"successCriteria\": \"Descriptive immune response\", \"sourceText\": \"Fold rise in serotype-specific OPA titers from before to 1 month after vaccination.\"}, {\"id\": \"2fbef8e8-b111-431b-bb1d-2ef8f9f53355\", \"name\": \"Safety: Adverse Events (AEs)\", \"endpointType\": \"Primary\", \"inputs\": [\"Adverse Events\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P1M\"}, \"algorithm\": \"count(AEs)\", \"successCriteria\": \"Descriptive safety profile\", \"sourceText\": \"Reported adverse events (AEs) within 1 month after vaccination.\"}, {\"id\": \"b1f3e7d0-2eec-46e6-8b87-8e14a8fdb367\", \"name\": \"Safety: SAEs and NDCMCs\", \"endpointType\": \"Primary\", \"inputs\": [\"Serious Adverse Events\", \"Newly Diagnosed Chronic Medical Conditions\"], \"timeWindow\": {\"reference\": \"vaccination\", \"duration\": \"P6M\"}, \"algorithm\": \"count(SAEs) + count(NDCMCs)\", \"successCriteria\": \"Descriptive safety profile\", \"sourceText\": \"Reported serious adverse events (SAEs) and newly diagnosed chronic medical conditions (NDCMCs) within 6 months after vaccination.\"}]"
              },
              {
                "id": "b786a93f-bd00-4011-b6c0-1f4a193ef50b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"e0f81e9d-6ad6-4acb-b6bc-0f0e131e0c58\", \"name\": \"Serotype-specific OPA GMTs\", \"variableType\": \"Custom\", \"sourceVariables\": [\"OPA titer\"], \"derivationRule\": \"exp(mean(ln(OPA titers)))\", \"baselineDefinition\": \"Sera collected before study vaccination (Visit 1)\", \"baselineVisit\": \"Visit 1\", \"analysisWindow\": \"1 month after each vaccination\", \"imputationRule\": \"Missing assay results will not be replaced or imputed. OPA titers below LLOQ handled per SAP.\", \"unit\": \"titer\"}, {\"id\": \"1adf1540-7888-44f0-9106-999abb2eb8a8\", \"name\": \"OPA GMR (20vPnC/saline to 13vPnC/PPSV23)\", \"variableType\": \"Custom\", \"sourceVariables\": [\"OPA titer\"], \"derivationRule\": \"exp(mean(ln(20vPnC group)) - mean(ln(13vPnC/PPSV23 group)))\", \"baselineDefinition\": \"N/A (Comparison between groups)\", \"baselineVisit\": \"N/A\", \"analysisWindow\": \"Visit 2 (13 matched serotypes); Visit 2 vs Visit 3 (7 additional serotypes)\", \"imputationRule\": \"Missing assay results will not be replaced or imputed.\", \"unit\": \"ratio\"}, {\"id\": \"ebdd2b90-1baf-43c7-99d1-3878e4178a8d\", \"name\": \"OPA GMFR\", \"variableType\": \"PercentChange\", \"sourceVariables\": [\"OPA titer\"], \"derivationRule\": \"Geometric mean of the ratios of post-vaccination titer to pre-vaccination titer\", \"baselineDefinition\": \"Sera collected before study vaccination (Visit 1)\", \"baselineVisit\": \"Visit 1\", \"analysisWindow\": \"Visit 1 to Visit 2 (20vPnC and 13vPnC matched); Visit 1 to Visit 3 (13vPnC/PPSV23 7 additional)\", \"imputationRule\": \"Limited to subjects with nonmissing values both before and after vaccination.\", \"unit\": \"ratio\"}, {\"id\": \"b68e09dc-4327-480f-8208-483f613d94e4\", \"name\": \"Proportion of subjects with OPA titers \\u2265LLOQ\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"OPA titer\", \"LLOQ\"], \"derivationRule\": \"(Count of subjects with titer >= LLOQ / Total subjects) * 100\", \"baselineDefinition\": \"Pre-vaccination (Visit 1)\", \"baselineVisit\": \"Visit 1\", \"analysisWindow\": \"Visit 1, Visit 2, and Visit 3 (as applicable per serotype)\", \"imputationRule\": \"Missing assay results will not be replaced or imputed.\", \"unit\": \"%\"}, {\"id\": \"41eddfb7-e95e-45c5-8390-124a33f73ca3\", \"name\": \"Proportion of subjects with \\u22654-fold rise in OPA titer\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"OPA titer\"], \"derivationRule\": \"(Count of subjects with (Post-vaccination titer / Pre-vaccination titer) >= 4 / Total subjects) * 100\", \"baselineDefinition\": \"Sera collected before study vaccination (Visit 1)\", \"baselineVisit\": \"Visit 1\", \"analysisWindow\": \"Visit 1 to Visit 2 (20vPnC and 13vPnC matched); Visit 1 to Visit 3 (13vPnC/PPSV23 7 additional)\", \"imputationRule\": \"Missing assay results will not be replaced or imputed.\", \"unit\": \"%\"}, {\"id\": \"3df37243-f54b-4672-a23a-7c8f17cd27e5\", \"name\": \"OPA GMR (Age Bridging)\", \"variableType\": \"Custom\", \"sourceVariables\": [\"OPA titer\"], \"derivationRule\": \"exp(mean(ln(Younger Cohort)) - mean(ln(Older Cohort)))\", \"baselineDefinition\": \"N/A (Comparison between age cohorts)\", \"baselineVisit\": \"N/A\", \"analysisWindow\": \"Visit 2 (1 month after vaccination)\", \"imputationRule\": \"Missing assay results will not be replaced or imputed.\", \"unit\": \"ratio\"}]"
              },
              {
                "id": "86fb1704-2f31-432d-a944-15a5953e287e",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"e4ea693d-23cf-47a1-9e7f-7064152c75b1\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Vaccination 1\", \"Vaccination 2 Or Follow Up\", \"Immunogenicity Follow Up\", \"End Of Study Telephone Contact\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Vaccination 1\", \"trigger\": \"Progress to Vaccination 1\"}, {\"fromState\": \"Vaccination 1\", \"toState\": \"Vaccination 2 Or Follow Up\", \"trigger\": \"Progress to Vaccination 2 Or Follow Up\"}, {\"fromState\": \"Vaccination 2 Or Follow Up\", \"toState\": \"Immunogenicity Follow Up\", \"trigger\": \"Progress to Immunogenicity Follow Up\"}, {\"fromState\": \"Immunogenicity Follow Up\", \"toState\": \"End Of Study Telephone Contact\", \"trigger\": \"Progress to End Of Study Telephone Contact\"}], \"epochIds\": {\"Screening\": \"SCREENING\", \"Vaccination 1\": \"VACCINATION_1\", \"Vaccination 2 Or Follow Up\": \"VACCINATION_2_OR_FOLLOW_UP\", \"Immunogenicity Follow Up\": \"IMMUNOGENICITY_FOLLOW_UP\", \"End Of Study Telephone Contact\": \"END_OF_STUDY_TELEPHONE_CONTACT\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "82105454-1243-415f-9a0b-b53e902a42f6",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"276ea538-34f8-4bd8-ba4f-247607d913cf\", \"treatmentName\": \"20-valent Pneumococcal Conjugate Vaccine (20vPnC) / PF-06482077\", \"frequency\": \"Single\", \"route\": \"IM\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"dose\", \"description\": \"Single injection\"}], \"durationDescription\": \"1 day\"}, {\"id\": \"b3fe5171-eca1-4be5-96d9-d4b929261861\", \"treatmentName\": \"Comparator / Placebo\", \"frequency\": \"Single\", \"route\": \"IM\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"dose\", \"description\": \"Matching active vaccine\"}], \"durationDescription\": \"1 day\"}]"
              },
              {
                "id": "7163230e-20f6-464f-9ec1-cb71e6fef77d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"59618530-18a9-488f-961d-b57754497e03\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"sourceText\": \"or sponsor include, but are not limited to, failure to meet entrance criteria (screening failure), AE, death, pregnancy, protocol deviation, lost to follow-up, no longer willing to participate in the \"}, {\"id\": \"08aa2ab7-deff-446a-ab35-f0d349bfba9e\", \"visitName\": \"Visit 2\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"6.1.2. Cohort 1: Visit 2 (Vaccination 2 \\u2013 28 to 42 Days After Visit 1)................41 6.1.3. Cohort 1: Visit 3 (Follow-up \\u2013 28 to 42 Days After Vaccination 2)..........42\"}, {\"id\": \"5ed2cbed-e98c-4f69-b9e0-054cd55c61f5\", \"visitName\": \"Visit 3\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 3, \"sourceText\": \"6.1.3. Cohort 1: Visit 3 (Follow-up \\u2013 28 to 42 Days After Vaccination 2)..........42\"}, {\"id\": \"ef21e966-60bb-4ab3-9241-debc2b80c881\", \"visitName\": \"Visit 4\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 4, \"sourceText\": \"6.1.4. Cohort 1: Visit 4 (6-Month Safety Collection [Telephone Contact] \\u2013 168 to 196 Days After Vaccination 1).............................................................42 6.2. Cohorts 2 and 3 .....\"}, {\"id\": \"146129bd-b4ae-42d4-98e6-eeffe8c11caa\", \"visitName\": \"Cohort 1: Visit 4 (6-Month Safety Collection [Telephone Contact])\", \"targetDay\": 182, \"windowBefore\": 14, \"windowAfter\": 14, \"isRequired\": true, \"visitNumber\": 4, \"targetWeek\": 26, \"epoch\": \"Cohort 1\"}, {\"id\": \"fe28f81a-119f-4b09-86ea-35fc3036b8ec\", \"visitName\": \"Visit 23\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"Subjects in Cohort 1 who received 13vPnC at Vaccination 1 will receive PPSV23 at Vaccination 2. Approximately 2000 subjects 60 through 64 years of age and 1000 subjects 65 years of age and older will \"}, {\"id\": \"40cd923c-b7ab-4a81-a5c5-e66b9cc0b574\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"establish a clinical baseline. Significant medical history, significant findings from any physical examination, if performed, and temperature measurements will be documented and recorded in the source\"}, {\"id\": \"f071b171-af87-478d-92cb-20e26bb32099\", \"visitName\": \"Unscheduled Visits\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": false, \"visitNumber\": 8, \"epoch\": \"All Cohorts\"}, {\"id\": \"eb24b034-5190-4f21-842b-a901ad47e65c\", \"visitName\": \"randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 9, \"epoch\": \"Cohort 1\", \"sourceText\": \"Assign randomization number  Obtain blood sample for immunogenicity (~50 mL)c\"}, {\"id\": \"86e18e8c-9ec5-4b3c-8f6f-35bc67aa14db\", \"visitName\": \"Day 7\", \"targetDay\": 7, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"sourceText\": \"each day will be recorded in the e-diary. In the event of a fever on Day 7, temperature will be collected daily until fever has resolved (1 day of temperature <100.4\\uf0b0F [<38.0\\uf0b0C]) in order to collect a\"}, {\"id\": \"06ffec6e-3241-4d31-acba-2dc4012ac1e5\", \"visitName\": \"Cohort 1: Visit 2 (Vaccination 2)\", \"targetDay\": 35, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 2, \"targetWeek\": 5, \"epoch\": \"Cohort 1\"}, {\"id\": \"589867b0-128d-404e-b2be-28f10569c7af\", \"visitName\": \"Cohort 1: Visit 3 (Follow-up)\", \"targetDay\": 70, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 3, \"targetWeek\": 10, \"epoch\": \"Cohort 1\"}, {\"id\": \"e45fe558-8f5c-43f4-85f4-0d265a366c56\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 14, \"sourceText\": \"6.1.3. Cohort 1: Visit 3 (Follow-up \\u2013 28 to 42 Days After Vaccination 2)..........42\"}]"
              },
              {
                "id": "a1e2a028-b57e-4dbe-9526-a44b7a7e7ef5",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"659ee4de-45aa-4ce5-b8ef-41e38beab38d\", \"ratio\": \"Cohort 1: 1:1; Cohort 2: 3:1; Cohort 3: 3:1\", \"method\": \"Randomized, double-blind\", \"centralRandomization\": true, \"blockSize\": \"Not specified\", \"stratificationFactors\": [{\"id\": \"29ce1469-e1b0-48d8-85ab-b44c257087ae\", \"name\": \"Age\", \"categories\": [\"<49 years\", \"\\u226549 years\"], \"isBlocking\": false, \"sourceText\": \"age\"}, {\"id\": \"ff1dd851-b372-414e-bd87-400f8b38eea1\", \"name\": \"Age (Cohort 1)\", \"categories\": [\"60 through 64 years of age\", \"65 years of age and older\"], \"isBlocking\": false}, {\"id\": \"4b508659-e283-4ed0-81c9-132e0ea904e9\", \"name\": \"Cohort Assignment (Age-based)\", \"categories\": [\"Cohort 1: \\u226560 years\", \"Cohort 2: 50 through 59 years\", \"Cohort 3: 18 through 49 years\"], \"isBlocking\": false}], \"sourceText\": \"20-valent Pneumococcal Conjugate Vaccine (20vPnC)\\nB7471007\\nFinal Protocol Amendment 2, 11 February 2019\\nPFIZER CONFIDENTIAL\\nPage 12\\nPfizer is developing a new 20-valent pneumococcal conjugate vaccine \"}"
              },
              {
                "id": "ext_execution_model_5df42f45-e8a1-4eba-866d-cc2b01bf6998",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T04:30:11.669983",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "0357a113-8128-4402-bc3a-49e64da7e4a0",
                        "definition": "The day of the first vaccination (Vaccination 1)",
                        "anchorType": "Day1",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 80,
                        "sourceText": "Visit Number 1, Visit Description Vaccination 1, Visit Window (Days) Day 1",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "229c9103-863e-4df9-829c-f2fb0743996b",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 10,
                        "sourceText": "informed consent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "e9e6af96-3ef6-45a8-9345-b9d854add030",
                        "definition": "procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "c262d1c4-7971-4c52-979b-333ad2b6ea3a",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "4bb9d24b-5cb3-4a2e-95ec-e846155e53bc",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "OD"
                      },
                      {
                        "id": "c8343ecd-b1b4-461e-81e9-afdb338c1443",
                        "type": "Continuous",
                        "sourceText": "42 Days After"
                      },
                      {
                        "id": "d7c03c57-11c1-46ef-b8d8-c076978407dc",
                        "type": "Continuous",
                        "sourceText": "196 Days After"
                      },
                      {
                        "id": "a24800f9-8a0a-4ffd-9722-3bd379763289",
                        "type": "Continuous",
                        "sourceText": "7 days after"
                      },
                      {
                        "id": "72fb1c6e-786a-4167-92da-3598b3580127",
                        "type": "Continuous",
                        "sourceText": "10 days after"
                      },
                      {
                        "id": "5c6db31d-ed37-47b7-a888-560577e7a15d",
                        "type": "Continuous",
                        "sourceText": "42 days after"
                      },
                      {
                        "id": "f1d60db3-23b6-47e1-8500-10ffdc2a66ec",
                        "type": "Continuous",
                        "sourceText": "42 Days \nAfter"
                      },
                      {
                        "id": "e722dbc2-fcc6-4cd7-a414-8648b1d4f18c",
                        "type": "Continuous",
                        "sourceText": "196 Days \nAfter"
                      },
                      {
                        "id": "c5083d8f-83b9-409a-a3c1-5a312e1d0919",
                        "type": "Continuous",
                        "sourceText": "28 days after"
                      },
                      {
                        "id": "378fda08-6eaa-4148-850f-d42be15c2d5d",
                        "type": "Continuous",
                        "sourceText": "42 Days\nAfter"
                      },
                      {
                        "id": "0f69240a-02ac-4f38-be11-3805b993782f",
                        "type": "Continuous",
                        "sourceText": "28 days before"
                      },
                      {
                        "id": "2c372c8d-b85f-43e9-96d7-0f7294c91fb3",
                        "type": "Continuous",
                        "sourceText": "60 days before"
                      },
                      {
                        "id": "5f72d130-1c6b-4a6c-a8a8-559262372e68",
                        "type": "Continuous",
                        "sourceText": "48 hours before"
                      },
                      {
                        "id": "1f67c13e-5b5b-4c72-9e50-2a8102744e53",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "endOffset": "P42D",
                        "interval": "P28D",
                        "minObservations": 2,
                        "exitCondition": "Completion of Vaccination 2",
                        "sourceText": "Cohort 1: Visit 2 (Vaccination 2  28 to 42 Days After Visit 1)"
                      },
                      {
                        "id": "889a2edb-51f8-4c5a-a36b-90341a28af90",
                        "type": "Continuous",
                        "startOffset": "P168D",
                        "endOffset": "P196D",
                        "interval": "P1D",
                        "minObservations": 1,
                        "exitCondition": "Completion of 6-Month Safety Collection",
                        "sourceText": "6-Month Safety Collection [Telephone Contact]  168 to 196 Days After Vaccination 1"
                      },
                      {
                        "id": "e2aac58a-4417-404d-9b20-1851d171cc2e",
                        "type": "Daily",
                        "startOffset": "P0D",
                        "endOffset": "null",
                        "interval": "P1D",
                        "minObservations": 7,
                        "exitCondition": "End of diary reporting period",
                        "sourceText": "7.2.1. Subject Electronic Diary"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "0a681b9c-1411-4ae0-9496-34028e2b2dc2",
                        "requiredSequence": [
                          "epoch_1"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "c2243432-6e60-4682-86f8-0a731de79e28"
                        ],
                        "mandatoryVisits": [
                          "Screening",
                          "Visit 2 (Day 28-42)",
                          "Day 1",
                          "Visit 4 (6-Month Telephone Contact)",
                          "Visit 1 (Day 1)",
                          "End of Study"
                        ],
                        "sourceText": "[{'condition': 'Subject is in Cohort 1 (Age >= 60)', 'path': ['Visit 1 (Vaccination 1)', 'Visit 2 (Vaccination 2)', 'Visit 3 (Blood Draw)', 'Visit 4 (6-Month Follow-up)']}, {'condition': 'Subject is in Cohort 2 or 3 (Age 18-59)', 'path': ['Visit 1 (Vaccination 1)', 'Visit 2 (Blood Draw)', 'Visit 4 (6-Month Follow-up)']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Blood Draw",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 3"
                      },
                      {
                        "activityId": "Ae",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 3"
                      },
                      {
                        "activityId": "Diary",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Physical examination based on medical history",
                        "executionType": "Single",
                        "rationale": "The protocol describes this as a clinical assessment performed at the start of the study based on medical history."
                      },
                      {
                        "activityId": "Temperature monitoring",
                        "executionType": "Single",
                        "rationale": "Table 7 and Section 7.2 describe temperature ranges and monitoring following vaccination, which typically involves a continuous daily window of collection."
                      },
                      {
                        "activityId": "SAE reporting within 30 days",
                        "executionType": "Single",
                        "rationale": "The investigator must contact the sponsor if an SAE occurs; this is a conditional workflow triggered by a specific event."
                      },
                      {
                        "activityId": "Immunogenicity bridging analysis",
                        "executionType": "Single",
                        "rationale": "This is a specific data analysis activity performed once to compare cohorts."
                      },
                      {
                        "activityId": "Clinical assessment",
                        "executionType": "Single",
                        "rationale": "The Schedule of Activities and Amendment 1 notes indicate this is a repeated activity at study visits with added flexibility in wording."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "8209395d-4ea5-45b3-b983-e43f98314f83",
                        "conditionType": "procedure_timepoints",
                        "text": "a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV23 at Visit 2.",
                        "footnoteId": "e655500b-403f-4aee-b480-46ee269d07f1",
                        "structuredCondition": "group == 'Control' && time >= Visit1 && time < Visit2",
                        "appliesToActivityIds": [
                          "13vPnC Vaccination"
                        ],
                        "sourceText": "a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV2"
                      },
                      {
                        "id": "281d2d37-8e84-45f0-babe-eec2674ba4d7",
                        "conditionType": "timing_after",
                        "text": "b. Control group after vaccination with PPSV23 at Visit 2.",
                        "footnoteId": "e78e2a9a-1e7c-4938-9602-2d5721149025",
                        "structuredCondition": "group == 'Control' && time >= Visit2",
                        "appliesToActivityIds": [
                          "PPSV23 Vaccination"
                        ],
                        "sourceText": "b. Control group after vaccination with PPSV23 at Visit 2."
                      },
                      {
                        "id": "e1829c11-de7f-4fa4-8876-30f3f112aec1",
                        "conditionType": "timing_after",
                        "text": "c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months after Visit 1.",
                        "footnoteId": "245467f9-3b61-4131-9aef-175f3659dcba",
                        "structuredCondition": "collection.duration(SAE, NDCMC) <= P6M",
                        "appliesToActivityIds": [
                          "SAE Collection",
                          "NDCMC Collection"
                        ],
                        "sourceText": "c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months a"
                      },
                      {
                        "id": "5c4afbd1-ddbd-4032-bd70-1cacc0ce9a94",
                        "conditionType": "timing_before",
                        "text": "4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects are enrolled. The following eligibility criteria are designed to select subjects for whom participation in the study is considered appropriate. All relevant medical and nonmedical conditions should be taken into consideration when deciding whether a particular subject is suitable for this protocol. Subject eligibility should be reviewed and documented by an appropriate member of the investigators study team before subjects are included in the study.",
                        "footnoteId": "c5033d7d-8e3b-40ba-ab02-2e77167a34ce",
                        "structuredCondition": "eligibility.review_status == 'documented'",
                        "appliesToActivityIds": [
                          "Subject Enrollment"
                        ],
                        "sourceText": "4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects a"
                      },
                      {
                        "id": "5539d932-1b0c-4495-8581-a0c41b25d553",
                        "conditionType": "general",
                        "text": "1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.",
                        "footnoteId": "26456239-ad54-4db7-bd93-fd4ad5349a27",
                        "structuredCondition": "subject.has_signed_icd == true",
                        "appliesToActivityIds": [
                          "Informed Consent"
                        ],
                        "sourceText": "1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the sub"
                      },
                      {
                        "id": "c80a6946-826e-4c5f-bf7a-324b8d99457b",
                        "conditionType": "general",
                        "text": "2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures.",
                        "footnoteId": "302a49fe-6814-4354-8af0-04bfb955e2fa",
                        "structuredCondition": "subject.compliance_willingness == true",
                        "appliesToActivityIds": [
                          "All Study Procedures"
                        ],
                        "sourceText": "2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures."
                      },
                      {
                        "id": "cfddda6d-a7a8-48f0-9f52-d5fbd9efd200",
                        "conditionType": "general",
                        "text": "3. Expected to be available for the duration of the study and can be contacted by telephone during study participation.",
                        "footnoteId": "124b3f54-12ce-4a28-aa72-c155ada0b466",
                        "structuredCondition": "subject.availability == true && subject.phone_contactable == true",
                        "appliesToActivityIds": [
                          "All Study Procedures"
                        ],
                        "sourceText": "3. Expected to be available for the duration of the study and can be contacted by telephone during s"
                      },
                      {
                        "id": "f9e51278-5f95-4d44-82f0-34f77e26bcf6",
                        "conditionType": "general",
                        "text": "5. Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease,",
                        "footnoteId": "c74f34bf-66d4-422d-a12c-94d89fede7e7",
                        "structuredCondition": "subject.age_group == 'Adult' && subject.disease_status == 'stable'",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "5. Adults determined by clinical assessment, including medical history and clinical judgment, to be "
                      },
                      {
                        "id": "5ac57b58-111e-4a1c-8029-3321ae3ff2e5",
                        "conditionType": "timing_after",
                        "text": "6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father children; male subject who is able to father children and willing to use a highly effective method of contraception as outlined in this protocol until at least 28 days after the last dose of investigational product. Cohorts 2 and 3 only: Female subject of childbearing potential or male subject who is able to father children, and willing to use a highly effective method of contraception as outlined in this protocol for at least 28 days after the last dose of investigational product; or female subject not of childbearing potential or male subject not able to father children.",
                        "footnoteId": "f97dc83e-ce12-408f-b5c5-c521643d33ba",
                        "structuredCondition": "(cohort == 1 && subject.fertility == false) || (cohort == 1 && subject.fertility == true && contraception.duration >= P28D) || (cohort.in([2,3]) && contraception.duration >= P28D)",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father chi"
                      },
                      {
                        "id": "1873eec3-6a64-4c58-8b62-39a84c3be7a1",
                        "conditionType": "general",
                        "text": "7. History of microbiologically proven invasive disease caused by S pneumoniae.",
                        "footnoteId": "408e643a-f75a-41f0-b0f3-4416eda37988",
                        "structuredCondition": "subject.history.invasive_s_pneumoniae == true",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "7. History of microbiologically proven invasive disease caused by S pneumoniae."
                      },
                      {
                        "id": "51fa5930-c323-4c3f-af40-d9c5b8fae5f1",
                        "conditionType": "timing_before",
                        "text": "8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids, or planned receipt through the last blood draw. If systemic corticosteroids have been administered short term (<14 days) for treatment of an acute illness, subjects should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 28 days before investigational product administration. Inhaled/nebulized, intra-articular, intrabursal, or topical (skin or eyes) corticosteroids are permitted.",
                        "footnoteId": "70bacd84-d044-46c2-b302-f04e38e7fb48",
                        "structuredCondition": "subject.medication.immunosuppressive == false && (subject.medication.corticosteroids.short_term == true ? washout >= P28D : true)",
                        "appliesToActivityIds": [
                          "Enrollment",
                          "Investigational Product Administration"
                        ],
                        "sourceText": "8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or syst"
                      },
                      {
                        "id": "37701436-7e0a-404a-918d-db6adaf512ee",
                        "conditionType": "general",
                        "text": "9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppression, including, but not limited to, immunoglobulin class/subclass deficiencies, generalized malignancy, human immunodeficiency virus (HIV) infection, leukemia, lymphoma, or organ or bone marrow transplant.",
                        "footnoteId": "20d7a33a-d30c-4a1e-b58a-99393a3c8309",
                        "structuredCondition": "subject.immunodeficiency == false && subject.malignancy == false && subject.hiv == false",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppr"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "61c9fd9f-98f2-422a-ade9-76550e797a05",
                        "name": "Primary Safety: Local Reactions",
                        "endpointType": "Primary",
                        "inputs": [
                          "redness",
                          "swelling",
                          "pain at injection site"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P10D"
                        },
                        "algorithm": "count(reported_prompted_local_reactions)",
                        "successCriteria": "Descriptive safety profile",
                        "sourceText": "Reported prompted local reactions (redness, swelling, and pain at the injection site) within 10 days after vaccination."
                      },
                      {
                        "id": "8c3d9be2-31e7-4f1a-8ca9-6a874d39b581",
                        "name": "Primary Safety: Systemic Events",
                        "endpointType": "Primary",
                        "inputs": [
                          "fever",
                          "headache",
                          "fatigue",
                          "muscle pain",
                          "joint pain"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P7D"
                        },
                        "algorithm": "count(reported_prompted_systemic_events)",
                        "successCriteria": "Descriptive safety profile",
                        "sourceText": "Reported prompted systemic events (fever, headache, fatigue, muscle pain, and joint pain) within 7 days after vaccination."
                      },
                      {
                        "id": "a37af72c-f2a2-4a1e-b332-2624edbc8363",
                        "name": "Primary Immunogenicity: OPA Titers (Cohort 1)",
                        "endpointType": "Primary",
                        "inputs": [
                          "serotype-specific OPA titers"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P1M"
                        },
                        "algorithm": "Geometric Mean Titers (GMTs) comparison (20vPnC vs 13vPnC/PPSV23)",
                        "successCriteria": "Noninferiority to 13vPnC (13 serotypes) and PPSV23 (7 additional serotypes)",
                        "sourceText": "Serotype-specific opsonophagocytic activity (OPA) titers 1 month after vaccination."
                      },
                      {
                        "id": "8c340b91-e576-4d5f-ab08-bd3a962d6dec",
                        "name": "Secondary Immunogenicity: OPA Titers (Cohort 2 & 3)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "serotype-specific OPA titers"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P1M"
                        },
                        "algorithm": "Geometric Mean Titers (GMTs) comparison (Cohort 2/3 vs Cohort 60-64 years)",
                        "successCriteria": "Noninferiority to immune responses induced by 20vPnC in adults 60 through 64 years of age",
                        "sourceText": "Serotype-specific OPA titers 1 month after vaccination."
                      },
                      {
                        "id": "d1b756b7-2135-4654-b283-2511387bb38a",
                        "name": "Secondary Immunogenicity: OPA Fold Rise",
                        "endpointType": "Secondary",
                        "inputs": [
                          "OPA_titer_baseline",
                          "OPA_titer_post_vaccination"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P1M"
                        },
                        "algorithm": "OPA_titer_post_vaccination / OPA_titer_baseline",
                        "successCriteria": "Descriptive immune response",
                        "sourceText": "Fold rise in serotype-specific OPA titers from before to 1 month after vaccination."
                      },
                      {
                        "id": "2fbef8e8-b111-431b-bb1d-2ef8f9f53355",
                        "name": "Safety: Adverse Events (AEs)",
                        "endpointType": "Primary",
                        "inputs": [
                          "Adverse Events"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P1M"
                        },
                        "algorithm": "count(AEs)",
                        "successCriteria": "Descriptive safety profile",
                        "sourceText": "Reported adverse events (AEs) within 1 month after vaccination."
                      },
                      {
                        "id": "b1f3e7d0-2eec-46e6-8b87-8e14a8fdb367",
                        "name": "Safety: SAEs and NDCMCs",
                        "endpointType": "Primary",
                        "inputs": [
                          "Serious Adverse Events",
                          "Newly Diagnosed Chronic Medical Conditions"
                        ],
                        "timeWindow": {
                          "reference": "vaccination",
                          "duration": "P6M"
                        },
                        "algorithm": "count(SAEs) + count(NDCMCs)",
                        "successCriteria": "Descriptive safety profile",
                        "sourceText": "Reported serious adverse events (SAEs) and newly diagnosed chronic medical conditions (NDCMCs) within 6 months after vaccination."
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "e0f81e9d-6ad6-4acb-b6bc-0f0e131e0c58",
                        "name": "Serotype-specific OPA GMTs",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "OPA titer"
                        ],
                        "derivationRule": "exp(mean(ln(OPA titers)))",
                        "baselineDefinition": "Sera collected before study vaccination (Visit 1)",
                        "baselineVisit": "Visit 1",
                        "analysisWindow": "1 month after each vaccination",
                        "imputationRule": "Missing assay results will not be replaced or imputed. OPA titers below LLOQ handled per SAP.",
                        "unit": "titer"
                      },
                      {
                        "id": "1adf1540-7888-44f0-9106-999abb2eb8a8",
                        "name": "OPA GMR (20vPnC/saline to 13vPnC/PPSV23)",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "OPA titer"
                        ],
                        "derivationRule": "exp(mean(ln(20vPnC group)) - mean(ln(13vPnC/PPSV23 group)))",
                        "baselineDefinition": "N/A (Comparison between groups)",
                        "baselineVisit": "N/A",
                        "analysisWindow": "Visit 2 (13 matched serotypes); Visit 2 vs Visit 3 (7 additional serotypes)",
                        "imputationRule": "Missing assay results will not be replaced or imputed.",
                        "unit": "ratio"
                      },
                      {
                        "id": "ebdd2b90-1baf-43c7-99d1-3878e4178a8d",
                        "name": "OPA GMFR",
                        "variableType": "PercentChange",
                        "sourceVariables": [
                          "OPA titer"
                        ],
                        "derivationRule": "Geometric mean of the ratios of post-vaccination titer to pre-vaccination titer",
                        "baselineDefinition": "Sera collected before study vaccination (Visit 1)",
                        "baselineVisit": "Visit 1",
                        "analysisWindow": "Visit 1 to Visit 2 (20vPnC and 13vPnC matched); Visit 1 to Visit 3 (13vPnC/PPSV23 7 additional)",
                        "imputationRule": "Limited to subjects with nonmissing values both before and after vaccination.",
                        "unit": "ratio"
                      },
                      {
                        "id": "b68e09dc-4327-480f-8208-483f613d94e4",
                        "name": "Proportion of subjects with OPA titers LLOQ",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "OPA titer",
                          "LLOQ"
                        ],
                        "derivationRule": "(Count of subjects with titer >= LLOQ / Total subjects) * 100",
                        "baselineDefinition": "Pre-vaccination (Visit 1)",
                        "baselineVisit": "Visit 1",
                        "analysisWindow": "Visit 1, Visit 2, and Visit 3 (as applicable per serotype)",
                        "imputationRule": "Missing assay results will not be replaced or imputed.",
                        "unit": "%"
                      },
                      {
                        "id": "41eddfb7-e95e-45c5-8390-124a33f73ca3",
                        "name": "Proportion of subjects with 4-fold rise in OPA titer",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "OPA titer"
                        ],
                        "derivationRule": "(Count of subjects with (Post-vaccination titer / Pre-vaccination titer) >= 4 / Total subjects) * 100",
                        "baselineDefinition": "Sera collected before study vaccination (Visit 1)",
                        "baselineVisit": "Visit 1",
                        "analysisWindow": "Visit 1 to Visit 2 (20vPnC and 13vPnC matched); Visit 1 to Visit 3 (13vPnC/PPSV23 7 additional)",
                        "imputationRule": "Missing assay results will not be replaced or imputed.",
                        "unit": "%"
                      },
                      {
                        "id": "3df37243-f54b-4672-a23a-7c8f17cd27e5",
                        "name": "OPA GMR (Age Bridging)",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "OPA titer"
                        ],
                        "derivationRule": "exp(mean(ln(Younger Cohort)) - mean(ln(Older Cohort)))",
                        "baselineDefinition": "N/A (Comparison between age cohorts)",
                        "baselineVisit": "N/A",
                        "analysisWindow": "Visit 2 (1 month after vaccination)",
                        "imputationRule": "Missing assay results will not be replaced or imputed.",
                        "unit": "ratio"
                      }
                    ],
                    "stateMachine": {
                      "id": "e4ea693d-23cf-47a1-9e7f-7064152c75b1",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Vaccination 1",
                        "Vaccination 2 Or Follow Up",
                        "Immunogenicity Follow Up",
                        "End Of Study Telephone Contact",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Vaccination 1",
                          "trigger": "Progress to Vaccination 1"
                        },
                        {
                          "fromState": "Vaccination 1",
                          "toState": "Vaccination 2 Or Follow Up",
                          "trigger": "Progress to Vaccination 2 Or Follow Up"
                        },
                        {
                          "fromState": "Vaccination 2 Or Follow Up",
                          "toState": "Immunogenicity Follow Up",
                          "trigger": "Progress to Immunogenicity Follow Up"
                        },
                        {
                          "fromState": "Immunogenicity Follow Up",
                          "toState": "End Of Study Telephone Contact",
                          "trigger": "Progress to End Of Study Telephone Contact"
                        }
                      ],
                      "epochIds": {
                        "Screening": "SCREENING",
                        "Vaccination 1": "VACCINATION_1",
                        "Vaccination 2 Or Follow Up": "VACCINATION_2_OR_FOLLOW_UP",
                        "Immunogenicity Follow Up": "IMMUNOGENICITY_FOLLOW_UP",
                        "End Of Study Telephone Contact": "END_OF_STUDY_TELEPHONE_CONTACT",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "276ea538-34f8-4bd8-ba4f-247607d913cf",
                        "treatmentName": "20-valent Pneumococcal Conjugate Vaccine (20vPnC) / PF-06482077",
                        "frequency": "Single",
                        "route": "IM",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "dose",
                            "description": "Single injection"
                          }
                        ],
                        "durationDescription": "1 day"
                      },
                      {
                        "id": "b3fe5171-eca1-4be5-96d9-d4b929261861",
                        "treatmentName": "Comparator / Placebo",
                        "frequency": "Single",
                        "route": "IM",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "dose",
                            "description": "Matching active vaccine"
                          }
                        ],
                        "durationDescription": "1 day"
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "59618530-18a9-488f-961d-b57754497e03",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "sourceText": "or sponsor include, but are not limited to, failure to meet entrance criteria (screening failure), AE, death, pregnancy, protocol deviation, lost to follow-up, no longer willing to participate in the "
                      },
                      {
                        "id": "08aa2ab7-deff-446a-ab35-f0d349bfba9e",
                        "visitName": "Visit 2",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "6.1.2. Cohort 1: Visit 2 (Vaccination 2  28 to 42 Days After Visit 1)................41 6.1.3. Cohort 1: Visit 3 (Follow-up  28 to 42 Days After Vaccination 2)..........42"
                      },
                      {
                        "id": "5ed2cbed-e98c-4f69-b9e0-054cd55c61f5",
                        "visitName": "Visit 3",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 3,
                        "sourceText": "6.1.3. Cohort 1: Visit 3 (Follow-up  28 to 42 Days After Vaccination 2)..........42"
                      },
                      {
                        "id": "ef21e966-60bb-4ab3-9241-debc2b80c881",
                        "visitName": "Visit 4",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 4,
                        "sourceText": "6.1.4. Cohort 1: Visit 4 (6-Month Safety Collection [Telephone Contact]  168 to 196 Days After Vaccination 1).............................................................42 6.2. Cohorts 2 and 3 ....."
                      },
                      {
                        "id": "31651158-11e9-418e-9fad-4df31bb21ec0",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "6.1.4. Cohort 1: Visit 4 (6-Month Safety Collection [Telephone Contact]  168 to 196 Days After Vaccination 1).............................................................42 6.2. Cohorts 2 and 3 ....."
                      },
                      {
                        "id": "fe28f81a-119f-4b09-86ea-35fc3036b8ec",
                        "visitName": "Visit 23",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "Subjects in Cohort 1 who received 13vPnC at Vaccination 1 will receive PPSV23 at Vaccination 2. Approximately 2000 subjects 60 through 64 years of age and 1000 subjects 65 years of age and older will "
                      },
                      {
                        "id": "40cd923c-b7ab-4a81-a5c5-e66b9cc0b574",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "establish a clinical baseline. Significant medical history, significant findings from any physical examination, if performed, and temperature measurements will be documented and recorded in the source"
                      },
                      {
                        "id": "f071b171-af87-478d-92cb-20e26bb32099",
                        "visitName": "Unscheduled Visits",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": false,
                        "visitNumber": 8,
                        "epoch": "All Cohorts"
                      },
                      {
                        "id": "eb24b034-5190-4f21-842b-a901ad47e65c",
                        "visitName": "randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 9,
                        "epoch": "Cohort 1",
                        "sourceText": "Assign randomization number  Obtain blood sample for immunogenicity (~50 mL)c"
                      },
                      {
                        "id": "86e18e8c-9ec5-4b3c-8f6f-35bc67aa14db",
                        "visitName": "Day 7",
                        "targetDay": 7,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "sourceText": "each day will be recorded in the e-diary. In the event of a fever on Day 7, temperature will be collected daily until fever has resolved (1 day of temperature <100.4F [<38.0C]) in order to collect a"
                      },
                      {
                        "id": "06ffec6e-3241-4d31-acba-2dc4012ac1e5",
                        "visitName": "Cohort 1: Visit 2 (Vaccination 2)",
                        "targetDay": 35,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 2,
                        "targetWeek": 5,
                        "epoch": "Cohort 1"
                      },
                      {
                        "id": "589867b0-128d-404e-b2be-28f10569c7af",
                        "visitName": "Cohort 1: Visit 3 (Follow-up)",
                        "targetDay": 70,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 3,
                        "targetWeek": 10,
                        "epoch": "Cohort 1"
                      },
                      {
                        "id": "146129bd-b4ae-42d4-98e6-eeffe8c11caa",
                        "visitName": "Cohort 1: Visit 4 (6-Month Safety Collection [Telephone Contact])",
                        "targetDay": 182,
                        "windowBefore": 14,
                        "windowAfter": 14,
                        "isRequired": true,
                        "visitNumber": 4,
                        "targetWeek": 26,
                        "epoch": "Cohort 1"
                      },
                      {
                        "id": "e45fe558-8f5c-43f4-85f4-0d265a366c56",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 14,
                        "sourceText": "6.1.3. Cohort 1: Visit 3 (Follow-up  28 to 42 Days After Vaccination 2)..........42"
                      }
                    ],
                    "randomizationScheme": {
                      "id": "659ee4de-45aa-4ce5-b8ef-41e38beab38d",
                      "ratio": "Cohort 1: 1:1; Cohort 2: 3:1; Cohort 3: 3:1",
                      "method": "Randomized, double-blind",
                      "centralRandomization": true,
                      "blockSize": "Not specified",
                      "stratificationFactors": [
                        {
                          "id": "29ce1469-e1b0-48d8-85ab-b44c257087ae",
                          "name": "Age",
                          "categories": [
                            "<49 years",
                            "49 years"
                          ],
                          "isBlocking": false,
                          "sourceText": "age"
                        },
                        {
                          "id": "ff1dd851-b372-414e-bd87-400f8b38eea1",
                          "name": "Age (Cohort 1)",
                          "categories": [
                            "60 through 64 years of age",
                            "65 years of age and older"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "4b508659-e283-4ed0-81c9-132e0ea904e9",
                          "name": "Cohort Assignment (Age-based)",
                          "categories": [
                            "Cohort 1: 60 years",
                            "Cohort 2: 50 through 59 years",
                            "Cohort 3: 18 through 49 years"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "20-valent Pneumococcal Conjugate Vaccine (20vPnC)\nB7471007\nFinal Protocol Amendment 2, 11 February 2019\nPFIZER CONFIDENTIAL\nPage 12\nPfizer is developing a new 20-valent pneumococcal conjugate vaccine "
                    }
                  }
                }
              },
              {
                "id": "1882978b-1188-48f4-bae4-29503fd282f2",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. Control group from enrollment and vaccination with 13vPnC at Visit 1 until vaccination with PPSV23 at Visit 2.\", \"b. Control group after vaccination with PPSV23 at Visit 2.\", \"c. SAEs and newly diagnosed chronic medical conditions (NDCMCs) will be collected through 6 months after Visit 1.\", \"4. SUBJECT ELIGIBILITY CRITERIA This study can fulfill its objectives only if appropriate subjects are enrolled. The following eligibility criteria are designed to select subjects for whom participation in the study is considered appropriate. All relevant medical and nonmedical conditions should be taken into consideration when deciding whether a particular subject is suitable for this protocol. Subject eligibility should be reviewed and documented by an appropriate member of the investigator\\u2019s study team before subjects are included in the study.\", \"1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.\", \"2. Willing and able to comply with scheduled visits, treatment plan, and other study procedures.\", \"3. Expected to be available for the duration of the study and can be contacted by telephone during study participation.\", \"5. Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease,\", \"6. Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father children; male subject who is able to father children and willing to use a highly effective method of contraception as outlined in this protocol until at least 28 days after the last dose of investigational product. Cohorts 2 and 3 only: Female subject of childbearing potential or male subject who is able to father children, and willing to use a highly effective method of contraception as outlined in this protocol for at least 28 days after the last dose of investigational product; or female subject not of childbearing potential or male subject not able to father children.\", \"7. History of microbiologically proven invasive disease caused by S pneumoniae.\", \"8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids, or planned receipt through the last blood draw. If systemic corticosteroids have been administered short term (<14 days) for treatment of an acute illness, subjects should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 28 days before investigational product administration. Inhaled/nebulized, intra-articular, intrabursal, or topical (skin or eyes) corticosteroids are permitted.\", \"9. Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppression, including, but not limited to, immunoglobulin class/subclass deficiencies, generalized malignancy, human immunodeficiency virus (HIV) infection, leukemia, lymphoma, or organ or bone marrow transplant.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "edcd0e44-7fc9-45aa-933b-ddec243dd6b7",
                "name": "20-valent Pneumococcal Conjugate Vaccine (20vPnC) / PF-06482077 Administration",
                "instanceType": "Administration",
                "dose": "0.0 dose",
                "doseFrequency": "Single",
                "route": {
                  "id": "95b68e56-d5b2-4ed2-9e55-18f4ba829966",
                  "code": "IM",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IM",
                  "instanceType": "Code"
                },
                "duration": "1 day"
              },
              {
                "id": "a967032c-c407-477a-8a17-6e117f2fe093",
                "name": "Comparator / Placebo Administration",
                "instanceType": "Administration",
                "dose": "0.0 dose",
                "doseFrequency": "Single",
                "route": {
                  "id": "c7282e41-2159-4da8-a55e-eb6aba45ff00",
                  "code": "IM",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IM",
                  "instanceType": "Code"
                },
                "duration": "1 day"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "b9cca87d-06b1-4454-a751-e9ebca0f9ad9",
            "text": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINENAVE ADULTS 18 YEARS OF AGE AND OLDER",
            "type": {
              "id": "bb5d3c73-cc15-46ae-99b1-008867a9ef88",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "31901ae5-44be-414e-983a-437c6389a6c1",
            "text": "20-valent Pneumococcal Conjugate Vaccine (20vPnC)",
            "type": {
              "id": "59790dcf-65e9-4efe-8342-73d83eae851b",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "da48083c-7b86-4394-82ac-f9b2d21f0425",
            "text": "B7471007",
            "instanceType": "StudyIdentifier",
            "scopeId": "716a0648-e669-42c1-8a50-17c54188763c",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "7ebc2432-edfb-4b19-9e49-292454d4a46e",
            "text": "2018-004279-11",
            "instanceType": "StudyIdentifier",
            "scopeId": "ed7a6b79-7c3a-414e-9cc4-3bb7b237e269",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "09db3b0c-e900-42e2-b20b-2c5084252f0e",
            "text": "PF-06482077",
            "instanceType": "StudyIdentifier",
            "scopeId": "716a0648-e669-42c1-8a50-17c54188763c",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "716a0648-e669-42c1-8a50-17c54188763c",
            "name": "Pfizer",
            "type": {
              "id": "54c4de6b-7eb4-4f8d-b9d9-854f78777fa3",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Pfizer",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "1c8d2350-78b0-4a83-827c-041fc2f194b4",
            "name": "Swedish Medical Products Agency (MPA)",
            "type": {
              "id": "90d6fdc6-5d9f-4416-b866-c720d283f19e",
              "code": "C25461",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Regulatory Agency",
              "instanceType": "Code"
            },
            "identifier": "Swedish Medical Products Agency (MPA)",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "716a0648-e669-42c1-8a50-17c54188763c",
            "name": "Accel Research Sites",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "d78e40f7-a557-4f07-a652-0005242651f3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1c8d2350-78b0-4a83-827c-041fc2f194b4",
            "name": "Coastal Clinical Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "e10e4707-a684-4486-a919-d575e076518c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a2b1e0ce-954c-439f-8dfe-9905105a333c",
            "name": "East Valley Gastroenterology and Hepatology Associates",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "500d4e4d-494d-494f-912f-d812254abb96",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4d661582-62ee-45be-8a7b-739f986b2ae0",
            "name": "The Pain Center of Arizona",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "01184cfc-b05f-42e0-8463-06a84704f7b1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0eb006e0-69b4-41d9-a6cc-797ee8103d66",
            "name": "MedPharmics, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "10fb6492-04a2-4515-8659-413964c7e1c8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9a76eae6-346b-4da9-9551-6015ccd6eea7",
            "name": "HOPE Research Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "04e098e0-8e0f-4e73-a92f-c44d38654772",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "306ec370-9e4a-46f9-82e7-47549c0217e2",
            "name": "The Pain Center of Arizona",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "930d6619-25da-4d61-aa61-9f64b19d932e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "234dc621-1d52-4741-be87-375dcbeec893",
            "name": "Anaheim Clinical Trials, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "2eedb71b-1b1a-4629-9d38-c79d77f0941c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f2105dbb-cc84-4bb6-9892-4c99164d2dd6",
            "name": "Diablo Clinical Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "25d13fe6-b2b1-4e46-b6bf-4dff9b56d394",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "327ae22b-3b61-4b2d-9295-13a02b86edb6",
            "name": "Clinical Research Consulting, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "9b1ac03e-4dbc-4441-918e-c0a3bfbcd031",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7e170c10-05d9-4bf6-8e84-368f093aa398",
            "name": "Nature Coast Clinical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "2a315fed-04f8-4f0a-9b0a-7cf14d65b5fd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9e1c483e-0c44-4940-a9a0-b39da9b2c5fd",
            "name": "Accel Research Sites - Clinical Research Unit",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "37a19c80-d57e-4013-8079-a87bf772c2e0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b46f762b-683c-4ffb-85d5-7d15896736cf",
            "name": "Research Centers of America, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "cbe38bcd-f348-4260-ad36-5544fccc2fca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "11d70155-dd56-47bb-94ea-16e641148cbe",
            "name": "Jacksonville Center for Clinical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "686aa46b-c463-4896-80a8-27ed87283f77",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cb93eb67-526d-443d-adbb-8b1db7977ff0",
            "name": "Suncoast Research Group, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "b63f4857-ebc0-4a9a-bff4-575c50506a67",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4a5e1d1-9ca9-4f31-9c56-ae92edd53689",
            "name": "Acevedo Clinical Research Associates",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "2f09e31b-a8ab-48c9-91df-c9574b271634",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "de1a0b48-a918-494d-8458-58981f3a5756",
            "name": "Qps-Mra, Llc",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "58272ccf-f6bf-4ba6-8080-4a24c5daca68",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6f17a013-153e-47d6-b71f-e32deb5dcff8",
            "name": "Atlanta Center for Medical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "afc6b33e-2b15-44f6-a4e6-83b776d5d9ec",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7496cbee-a606-4efb-9d7e-0870e3932726",
            "name": "Meridian Clinical Research LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "d43169a7-71b9-4b39-9568-1e087ec0232c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fc0e35fd-ff84-4571-9179-44a00e85d28b",
            "name": "Clinical Research Atlanta",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "0b6b1b22-985f-4dc9-8f0d-fb4c6d7b0fca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d26d5315-0a0e-4d76-a1af-bbdff84f5381",
            "name": "East-West Medical Research Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "22d1f396-c919-4af2-8b8b-025ce89e13f7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ebebcdb7-1cc2-4d46-9e53-3eeb1b8a0782",
            "name": "Axtell Clinic, P.A.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "0c52a052-edbe-4432-b1aa-18ff44542676",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "85713a4e-1843-4aa7-a314-6c78c56e5df0",
            "name": "Heartland Research Associates, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "dbf6e76e-4154-4d43-8100-e9f726c36b7e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "686acbdb-e696-4f73-ad9c-7b159aa7f99f",
            "name": "Heartland Research Associates, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "53970557-f5bb-4a5e-bba9-5cab16a5f242",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c629e5c8-f803-4346-b1ac-e0034870b044",
            "name": "Northwest Family Physicians",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "9885de06-848b-46cb-8c1d-581193287a62",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d5358c93-9021-4c83-9248-7a73788c17e6",
            "name": "Heartland Research Associates, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "9134a155-33b2-4b9e-93ed-c0ecd8bd7f5b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "94d7e426-1344-49df-9a65-06448d3f1768",
            "name": "Meridian Clinical Research, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "4a0ccda0-c945-4dc3-b470-904c4b5060e5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "34f6e17a-ec51-40b1-b70f-4601184fcbde",
            "name": "Sundance Clinical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "8a38cc13-275e-49f7-9d48-31a61e190f06",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dd546f88-4946-4ed3-bac8-17ba18fa8bd6",
            "name": "Meridian Clinical Research, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "14e19f93-079c-465c-9eee-dd57f97bcc32",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2fb809a0-1070-43fe-aa80-fa411259e0e2",
            "name": "Meridian Clinical Research LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "6978d4eb-ea4b-4363-b6a2-9514433acc22",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dda234f0-d4f1-4dbe-93c8-5339a2d3ab71",
            "name": "ActivMed Practices & Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "d6afa1a8-ccd0-4dec-88c2-d4bae0628ec8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "003d8207-3b1f-48a3-8756-97bbca965d9b",
            "name": "United Medical Associates",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "ec09010b-0a3c-40c7-bee6-3be0888373c1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "96ce8e71-35a7-4670-af0d-1621eac565a0",
            "name": "Regional Clinical Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "8dc3eff9-0de4-4c79-b700-ce4faf28ace1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8aaf265b-69be-4ccd-983a-e18848b32388",
            "name": "Rochester Clinical Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "3c51c4b2-66df-4ff2-b8ff-a39a12a451ee",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9abc1939-efed-44e5-b4b6-166abb05a0b9",
            "name": "PharmQuest",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "98289c44-7d6a-4b4f-93d7-eef80d2a9b84",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "78998cfd-fd0a-4d3b-8733-5d05a9777719",
            "name": "M3 Wake Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "a1392ad4-0582-4268-b70f-1bbb5bdcaeb9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "caa132f1-e3fe-4612-b199-1d3db8544066",
            "name": "PMG Research of Wilmington, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "6204ddf7-cb03-49e1-911d-7af7305d9240",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "644a5c0a-2c22-4dbb-9d27-14b878faab1d",
            "name": "Lillestol Research LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "12069f74-7de9-45f7-a02e-4ab36d80d3e2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ce986e82-13e9-4fa4-a881-5597d73ae1e1",
            "name": "Cincinnati Children's Hospital Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "dfa4721d-7854-4661-b083-2fe081b74fb0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "82e9a53b-6f02-4fe3-b6ee-3722145d1afa",
            "name": "Sterling Research Group, Ltd.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "4bed15ac-24ee-4355-8a7d-d3c92282452e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "23ae8c87-1fc1-4b45-9f9b-a507b8be569b",
            "name": "Cincinnati Children's Hospital Medical Center (CCHMC)",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "2181958a-6e7d-4762-bffe-b186e6fbf369",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "920d19b9-9943-4e6c-8064-66daf19c4126",
            "name": "Sterling Research Group, Ltd.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "9414f2aa-8da8-43dc-9051-e2af6b1430ab",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "aabe995d-2261-4ae7-a55c-07e15c78643f",
            "name": "Rapid Medical Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "6f1a93c0-c80c-4819-89ca-00eb554389f6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ab9d16ab-1e4e-4168-8c42-71fde5f1fbf7",
            "name": "Lynn Health Science Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "ad32e907-e115-4175-bfd8-d449c0a2e375",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b92ef709-97f4-4149-b1f8-86bab5886ae2",
            "name": "Omega Medical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "07c10dc9-6ea8-4332-9833-feb45e63ad80",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1979fb86-fd37-4d70-b389-5c75825e8fd9",
            "name": "Meridian Clinical Research, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "0bccb75d-0884-4865-8280-222625f57ea7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3352db92-b84e-4e0f-aa52-d1b6e143286d",
            "name": "Tekton Research, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "50817011-212c-4cdc-9630-15ae83679cba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "12fabfb2-77da-43cd-b000-5c996f828f6a",
            "name": "Bellaire Doctor's Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "60263419-e87f-42c2-83c6-11f59f6d2cce",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9c9e6438-b362-49ff-9a69-5cf5f515b991",
            "name": "Ventavia Research Group, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "76844e7f-ffa4-4780-8fe2-cb276c6dc641",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "663db969-ebef-4bc1-9319-b08c4f3a9a6a",
            "name": "Benchmark Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "ebff9c06-d6b7-4b11-b02a-4e1532af3aa7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "14d77418-a6cc-4551-9fb3-9db45ae45804",
            "name": "HealthFirst Medical Group",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "51",
            "type": {
              "id": "3370031e-a40a-4f0e-b218-2b14f9879e50",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "043a9331-fe4d-44ae-9ccc-fdbc2e4be3ea",
            "name": "Ventavia Research Group, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "52",
            "type": {
              "id": "2d3e1967-46a3-4074-9439-a0e2bfdc7777",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ad559c39-469b-476b-bcb9-9000ade2fbc9",
            "name": "Clinical Trials of Texas, Inc.",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "53",
            "type": {
              "id": "7c1e9034-f686-4553-95da-718b8eda904b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7a97f47b-60a2-4ed3-a650-2cf3ae1d6c47",
            "name": "Ventavia Research Group, LLC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "54",
            "type": {
              "id": "b483f170-1969-4753-be2b-ee9a0bdbe5c7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "832418e3-d786-4452-a70e-36d6ad002cb2",
            "name": "DM Clinical Research",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "55",
            "type": {
              "id": "a4862925-f70c-48c7-9965-c97259c58a4e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d6ded488-aea7-4794-823e-c34200d2d134",
            "name": "Martin Diagnostic Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "56",
            "type": {
              "id": "57d34c25-595b-4ea1-999d-4de9f6997929",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9bcd7450-e2ec-4588-a65b-b88bb00c0af8",
            "name": "J. Lewis Research Inc. / Foothill Family Clinic Draper",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "57",
            "type": {
              "id": "538a5d6c-9f51-4f29-b09a-8b306f6edcaf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "522c8baf-6696-4454-8005-1923f97219c8",
            "name": "J. Lewis Research, Inc. / Foothill Family Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "58",
            "type": {
              "id": "7743824a-4708-4c85-a2e5-209c5d7429e6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0c6a3e2b-4a5f-4479-866f-796585be3453",
            "name": "J. Lewis Research, Inc. / Foothill Family Clinic South",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "59",
            "type": {
              "id": "09b9067d-8321-4216-ad5d-c4bdbc2f7dc0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "26115327-5894-456e-b46c-bafe74f7a950",
            "name": "J. Lewis Research, Inc. - Jordan River Family Medicine",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "60",
            "type": {
              "id": "c37431ed-8d1f-4596-bd66-0ff4447db1b2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7774cfdd-f6a5-4def-ad66-6eeb87bfcabf",
            "name": "Kaiser Permanente Washington Health Research Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "61",
            "type": {
              "id": "dd1e9fc4-a784-4f83-aeca-19bc468dd4ff",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3f59ae4c-76dc-4d14-b068-ab751abfcd88",
            "name": "Ladulaas Kliniska Studier",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "62",
            "type": {
              "id": "6f8c092a-34ec-4b2d-b066-080c79c4fe83",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1398a5b5-8185-4226-a705-95438a6a015a",
            "name": "Infektionskliniken Malarsjukhuset",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "63",
            "type": {
              "id": "a97d5329-8152-49a8-9e7f-cfd2bd147a1b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d1a34c76-79e9-4d73-85b4-a64edcafca90",
            "name": "ProbarE i Lund",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "64",
            "type": {
              "id": "9f328419-fe7e-4dc1-b851-8117885df1fc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9b5960f5-93b1-4c2d-9156-05274f8cfc7b",
            "name": "Avdelningen fr kliniska prvningar",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "65",
            "type": {
              "id": "e9cc96d5-a573-490d-8618-c79a9267fc7d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a6588d2c-5423-4fad-9aa2-df689c6ce8eb",
            "name": "Karolinska Trial Alliance, KTA Prim",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "66",
            "type": {
              "id": "fc6631a7-799b-4fa7-a1e2-a81f5f853e57",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eec2f315-eded-4794-acc9-6d40ddae4d40",
            "name": "Akardo Med Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "67",
            "type": {
              "id": "567d5afc-d921-4798-9737-ba27f3b53b96",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "203e58e0-8b00-444c-a100-8e35c9fc947c",
            "name": "Akademiska Sjukhuset",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "68",
            "type": {
              "id": "fa08d423-6eeb-437b-94d0-8e2653e23ea9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "45e529bc-6eb2-4370-90e1-51eff847e558",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "e071439c-7508-47bb-a102-98eebdd9722e",
            "name": "Informed Consent",
            "text": "Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5bffb81e-3a3d-47fe-a652-972f055ea34a",
            "name": "Compliance",
            "text": "Willing and able to comply with scheduled visits, treatment plan, and other study procedures.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4cc2f865-f722-4920-bbce-7fd491faf035",
            "name": "Availability",
            "text": "Expected to be available for the duration of the study and can be contacted by telephone during study participation.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6be66120-84e9-4cd6-90b2-355ff0c7c136",
            "name": "Age Cohorts",
            "text": "Cohort 1: Male or female adults 60 years of age and older. Cohort 2: Male or female adults 50 through 59 years of age. Cohort 3: Male or female adults 18 through 49 years of age.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8298ba18-c983-4a47-9b97-2aa4b6f17067",
            "name": "Stable Disease",
            "text": "Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease, defined as disease not requiring significant change in therapy in the previous 6 weeks or hospitalization for worsening disease within 12 weeks before receipt of investigational product.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2e1b6914-bdcd-4624-a07f-e066071f471a",
            "name": "Contraception",
            "text": "Cohort 1 only: Female subject of nonchildbearing potential or male subject not able to father children; male subject who is able to father children and willing to use a highly effective method of contraception as outlined in this protocol until at least 28 days after the last dose of investigational product. Cohorts 2 and 3 only: Female subject of childbearing potential or male subject who is able to father children, and willing to use a highly effective method of contraception as outlined in this protocol for at least 28 days after the last dose of investigational product; or female subject not of childbearing potential or male subject not able to father children.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b50fe4db-6262-4025-97d0-83dce092fd46",
            "name": "Site Staff Exclusion",
            "text": "Investigator site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the investigator, or subjects who are Pfizer employees, including their family members, directly involved in the conduct of the study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "76c0e741-0b7e-46ab-9026-df72c61b7291",
            "name": "Investigational Product Participation",
            "text": "Participation in other studies involving investigational drug(s), investigational vaccines, or investigational devices within 28 days prior to study entry and/or during study participation. Participation in purely observational studies is acceptable.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "1433f629-261d-4190-ad29-c17d0a5246eb",
            "name": "Prior Pneumococcal Vaccine",
            "text": "Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "28b79fc7-44cb-4c8a-a5ac-3a1d3d82c063",
            "name": "Severe Allergic Reaction",
            "text": "History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of 20vPnC, 13vPnC, or any other diphtheria toxoidcontaining vaccine or PPSV23.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "186ff9f8-45b9-47f5-989e-37f8aab684e9",
            "name": "Serious Chronic Disorder",
            "text": "Serious chronic disorder including metastatic malignancy, severe chronic obstructive pulmonary disease (COPD) requiring supplemental oxygen, end-stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder that, in the investigators opinion, excludes the subject from participating in the study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b5c965f6-e14f-442f-b30a-eabad6933983",
            "name": "Acute or Psychiatric Condition",
            "text": "Other acute or chronic medical or psychiatric condition including recent (within the past year) or active suicidal ideation or behavior or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c7653338-be5f-4664-9114-a6e28f52c290",
            "name": "Invasive S. pneumoniae Disease",
            "text": "History of microbiologically proven invasive disease caused by S pneumoniae.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "3b7215c0-39ee-4c2b-b2a6-bf09810d89b6",
            "name": "Immunosuppressive Therapy",
            "text": "Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids, or planned receipt through the last blood draw. If systemic corticosteroids have been administered short term (<14 days) for treatment of an acute illness, subjects should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 28 days before investigational product administration. Inhaled/nebulized, intra-articular, intrabursal, or topical (skin or eyes) corticosteroids are permitted.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0b40016c-d53d-46af-a794-b1f646f69443",
            "name": "Immunodeficiency",
            "text": "Subjects with known or suspected immunodeficiency or other conditions associated with immunosuppression, including, but not limited to, immunoglobulin class/subclass deficiencies, generalized malignancy, human immunodeficiency virus (HIV) infection, leukemia, lymphoma, or organ or bone marrow transplant.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "107097c2-59e4-4a79-8207-d7003b5da457",
            "name": "Bleeding Diathesis",
            "text": "Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "99c028a9-c10e-4589-8f65-c452e7e5b0d1",
            "name": "Blood Products",
            "text": "Receipt of blood/plasma products or immunoglobulin, from 60 days before investigational product administration, or planned receipt through study participation.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c18add5c-5661-4438-bdfb-31b5347319b6",
            "name": "Pregnancy or Breastfeeding",
            "text": "Pregnant female subjects or breastfeeding female subjects (known or suspected).",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "141f9944-2395-4422-9d8c-dc82a6ea79a3",
            "name": "20vPnC (PF-06482077)",
            "type": {
              "id": "5ae8735a-cdd9-4e74-a2f4-d780b921e605",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "9a2a0acb-c5fc-4b1a-8d9e-e8c54f292402",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "20-valent pneumococcal conjugate vaccine containing 20 S. pneumoniae serotypes conjugated to CRM197",
            "productIds": [
              "61dc7f16-ee11-484e-b066-7eed429acafd"
            ],
            "administrationIds": [
              "d37c02a7-7206-4010-afc9-671b587effd2"
            ]
          },
          {
            "id": "a656fc55-3be2-47c1-9115-dabe91448dac",
            "name": "13vPnC",
            "type": {
              "id": "18f9c208-59ad-4a2a-966f-0c5a36c44613",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "role": {
              "id": "34ac6aa2-4541-4d6d-aec3-34a45346a2f9",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Licensed 13-valent pneumococcal conjugate vaccine used as active comparator in Cohort 1",
            "productIds": [
              "8c16db0c-db81-43b3-bd52-bcd5f20ad85f"
            ],
            "administrationIds": [
              "c5ad2762-3b37-4e83-a343-92e41de53dfa"
            ]
          },
          {
            "id": "45813a89-a756-4dda-8c4a-be9c35feff2c",
            "name": "PPSV23",
            "type": {
              "id": "46d3a65c-0f29-43c3-8965-394a86605ca2",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "role": {
              "id": "bb29f8c2-49b9-4d69-b56b-728f290efaa5",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Licensed 23-valent pneumococcal polysaccharide vaccine used as active comparator in Cohort 1",
            "productIds": [
              "3db776be-3ccf-4a73-8377-a01de9e45836"
            ],
            "administrationIds": [
              "d4bf29f2-7275-41f5-a25e-45ab6af54dd7"
            ]
          },
          {
            "id": "2cc286eb-a69f-483c-aeaf-d177c103e964",
            "name": "Saline",
            "type": {
              "id": "df9a8f75-302b-4c85-85a4-18191ef0aa55",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "22fbd76c-ba2f-418c-84ec-698cf09b7ed3",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "0.9% sodium chloride injection used as placebo in Cohort 1",
            "productIds": [
              "90826556-b32a-4663-9a75-05e9e9238106"
            ]
          },
          {
            "id": "b321a034-5658-45f7-9559-01f9f55586ad",
            "name": "Antipyretic/Pain medication",
            "type": {
              "id": "9e386883-5f8d-483c-8355-aa8ec593968b",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "9ab79d83-6406-4256-9eb9-4c6cba2322d8",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted for treatment of symptoms; prophylactic use not recommended on the day of vaccination"
          },
          {
            "id": "d1342bc4-3d61-4692-bf94-08eee57a4f1e",
            "name": "Influenza vaccine",
            "type": {
              "id": "13d3da1f-4b2b-4a04-a814-4db3eb0a32a3",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "35fdc7b6-66b8-4341-97f7-bd5f4cd2a85f",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Licensed inactivated influenza vaccine permitted if given >14 days from study vaccination"
          },
          {
            "id": "184c486c-7d2a-4b73-8feb-4a8ce061b7fd",
            "name": "Systemic corticosteroids",
            "type": {
              "id": "2c441f36-0bda-422a-9662-60c9ad66d9e9",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "873d08bc-abd4-489d-8a4e-1df4dedacd1a",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited during study participation; requires 28-day washout if used short-term prior to enrollment"
          }
        ],
        "administrableProducts": [
          {
            "id": "61dc7f16-ee11-484e-b066-7eed429acafd",
            "name": "20vPnC",
            "administrableDoseForm": {
              "id": "2d95a531-7c9c-432b-978a-e16005662570",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "113086d5-5295-4d26-82f1-3e7575e82a44",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "a83c1315-ca37-418e-a9e8-ee9a20cbf358",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0.5 mL",
            "substanceIds": [
              "b62052bf-2eba-4141-ae53-18611f9948ac"
            ],
            "manufacturer": "Pfizer"
          },
          {
            "id": "8c16db0c-db81-43b3-bd52-bcd5f20ad85f",
            "name": "13vPnC",
            "administrableDoseForm": {
              "id": "c7b5a98c-3b79-4dd9-a1b1-a0fb192486f0",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "7d555da9-6587-4f7b-b89a-19d9aa0159b2",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "5bd0835c-0db0-4853-a1a8-c04e53da55fd",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0.5 mL",
            "substanceIds": [
              "190d0b35-fa69-4a76-8adb-33a026257aed"
            ],
            "manufacturer": "Pfizer"
          },
          {
            "id": "3db776be-3ccf-4a73-8377-a01de9e45836",
            "name": "PPSV23",
            "administrableDoseForm": {
              "id": "81f157cb-0b07-4f51-ace3-6892d8a6dafd",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "0ef97a19-ce87-4f7f-840f-87f3c4a72715",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "9a382f46-0c11-41a8-b215-890e7a1539af",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "25 mcg of each of 23 polysaccharide serotypes per 0.5 mL",
            "substanceIds": [
              "6a9dd8ef-8d42-435c-a4f6-59922d581fa9"
            ],
            "manufacturer": "Not specified (Licensed commercial product)"
          },
          {
            "id": "90826556-b32a-4663-9a75-05e9e9238106",
            "name": "Saline",
            "administrableDoseForm": {
              "id": "846d175b-a537-4648-8d7e-b587312b3810",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "2980d627-23a4-42ff-93bc-af6e4e7391eb",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "69f58732-8b81-4b07-87fd-8d6f737664d1",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0.9% sodium chloride",
            "manufacturer": "Not specified"
          }
        ],
        "narrativeContents": [
          {
            "id": "ce816973-74e6-4fd9-8d6c-a3e13aed167f",
            "name": "PROTOCOL SUMMARY",
            "text": "PROTOCOL SUMMARY",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "N/A",
            "sectionTitle": "PROTOCOL SUMMARY",
            "sectionType": {
              "id": "8b0aa6ac-d2a5-4932-8cd3-e7e7a85438f5",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            }
          },
          {
            "id": "14b4b2b6-d776-416e-a3ad-ef428aefdd44",
            "name": "SCHEDULE OF ACTIVITIES",
            "text": "SCHEDULE OF ACTIVITIES",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "N/A",
            "sectionTitle": "SCHEDULE OF ACTIVITIES",
            "sectionType": {
              "id": "21a44703-9f2b-4651-993f-bdbf578a16a1",
              "code": "Study Procedures",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Procedures",
              "instanceType": "Code"
            }
          },
          {
            "id": "0e5c412b-a614-46ac-a16f-81a869a843a4",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "598f108e-c07d-4bea-9e5a-9b51106fceb7",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "1c883bc8-b948-4a06-85ef-005a2980dea8",
              "d528ce69-a49e-411a-9e31-a1197434e721",
              "64028b24-a4a8-4f92-ac73-4cd19d8db81a",
              "a54dd0fc-e829-4497-bbbc-aba01ab1e61e",
              "25a14944-9f9e-4343-841c-5b5f95b6bce5",
              "cac5b071-95d4-4923-9541-1361c427c0aa",
              "f5e28ee6-c02b-4fe8-a942-ea010eac3511",
              "51a27f5f-a84f-436c-89f1-864f81668aea"
            ]
          },
          {
            "id": "a7af0c60-333d-4f32-b1ab-2b5a77eb48b6",
            "name": "STUDY OBJECTIVES AND ENDPOINTS",
            "text": "STUDY OBJECTIVES AND ENDPOINTS",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "STUDY OBJECTIVES AND ENDPOINTS",
            "sectionType": {
              "id": "3db728e6-13eb-47d9-b55a-7cd6636037a4",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            },
            "childIds": [
              "b6b81102-55de-426f-a942-937d25cd5bea",
              "f83cc00e-7b40-4da8-9f0d-da207e309609",
              "432cce50-2cb4-476b-b8f0-214a194b0f02",
              "30b58d7a-0b7b-4c3e-8abc-6c08267bd2e1",
              "f282f3b8-ed13-4fca-bbbd-23a588c08244",
              "abc1e9c1-3db8-4faa-af92-1a7297d32e23",
              "56081cff-7a3e-4524-b7c1-e8e1fbcf18c1",
              "0836d02f-35b9-41d5-a278-37be07221dcd",
              "3f9e2d9f-b893-4236-a09b-5e43c131f69f",
              "a66043aa-0888-45ce-9ad9-ebe8ba776f84"
            ]
          },
          {
            "id": "5d71057c-ffce-4d10-884f-c0c3ef862f95",
            "name": "STUDY DESIGN",
            "text": "STUDY DESIGN",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "STUDY DESIGN",
            "sectionType": {
              "id": "4e3cea58-ce31-4491-8c36-2db975e1ff82",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "3691f642-aa0c-4c28-96e8-704f60a635ea",
              "e7d637a8-c97d-4d99-81a6-e3027ace63e3"
            ]
          },
          {
            "id": "41a7e764-173d-4bf7-8548-81781ae66350",
            "name": "REFERENCES",
            "text": "REFERENCES",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "16",
            "sectionTitle": "REFERENCES",
            "sectionType": {
              "id": "c739129d-cab6-412d-8711-351cf1608c60",
              "code": "References",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "References",
              "instanceType": "Code"
            }
          },
          {
            "id": "ec9dea0e-60be-4f54-8672-53f416773145",
            "name": "APPENDICES",
            "text": "APPENDICES",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "N/A",
            "sectionTitle": "APPENDICES",
            "sectionType": {
              "id": "183a6693-115c-444c-bcda-7ab543f93b82",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            },
            "childIds": [
              "3013c967-600d-4a78-85d2-fa425489500f"
            ]
          }
        ],
        "narrativeContentItems": [
          {
            "id": "1c883bc8-b948-4a06-85ef-005a2980dea8",
            "name": "Indication",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "Indication"
          },
          {
            "id": "d528ce69-a49e-411a-9e31-a1197434e721",
            "name": "Background and Rationale",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "Background and Rationale"
          },
          {
            "id": "64028b24-a4a8-4f92-ac73-4cd19d8db81a",
            "name": "Pneumococcal Disease",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2.1",
            "sectionTitle": "Pneumococcal Disease"
          },
          {
            "id": "a54dd0fc-e829-4497-bbbc-aba01ab1e61e",
            "name": "Vaccines to Prevent Pneumococcal Disease",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2.2",
            "sectionTitle": "Vaccines to Prevent Pneumococcal Disease"
          },
          {
            "id": "25a14944-9f9e-4343-841c-5b5f95b6bce5",
            "name": "Pneumococcal Polysaccharide Vaccines",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2.2.1",
            "sectionTitle": "Pneumococcal Polysaccharide Vaccines"
          },
          {
            "id": "cac5b071-95d4-4923-9541-1361c427c0aa",
            "name": "Pneumococcal Polysaccharide Conjugate Vaccines",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2.2.2",
            "sectionTitle": "Pneumococcal Polysaccharide Conjugate Vaccines"
          },
          {
            "id": "f5e28ee6-c02b-4fe8-a942-ea010eac3511",
            "name": "Rationale for 20vPnC and Study B7471007",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2.2.3",
            "sectionTitle": "Rationale for 20vPnC and Study B7471007"
          },
          {
            "id": "51a27f5f-a84f-436c-89f1-864f81668aea",
            "name": "Benefit-Risk Assessment",
            "text": "",
            "order": 7,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.3",
            "sectionTitle": "Benefit-Risk Assessment"
          },
          {
            "id": "b6b81102-55de-426f-a942-937d25cd5bea",
            "name": "Primary Safety Objective (All Cohorts)",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "Primary Safety Objective (All Cohorts)"
          },
          {
            "id": "f83cc00e-7b40-4da8-9f0d-da207e309609",
            "name": "Primary Safety Endpoints (All Cohorts)",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1.1",
            "sectionTitle": "Primary Safety Endpoints (All Cohorts)"
          },
          {
            "id": "432cce50-2cb4-476b-b8f0-214a194b0f02",
            "name": "Primary Immunogenicity Objectives  Cohort 1 (60 Years of Age and Older)",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "Primary Immunogenicity Objectives  Cohort 1 (60 Years of Age and Older)"
          },
          {
            "id": "30b58d7a-0b7b-4c3e-8abc-6c08267bd2e1",
            "name": "Primary Immunogenicity Endpoint  Cohort 1 (60 Years of Age and Older)",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2.1",
            "sectionTitle": "Primary Immunogenicity Endpoint  Cohort 1 (60 Years of Age and Older)"
          },
          {
            "id": "f282f3b8-ed13-4fca-bbbd-23a588c08244",
            "name": "Secondary Objective  Cohort 2 (50 Through 59 Years of Age)",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "Secondary Objective  Cohort 2 (50 Through 59 Years of Age)"
          },
          {
            "id": "abc1e9c1-3db8-4faa-af92-1a7297d32e23",
            "name": "Secondary Endpoint  Cohort 2 (50 Through 59 Years of Age)",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3.1",
            "sectionTitle": "Secondary Endpoint  Cohort 2 (50 Through 59 Years of Age)"
          },
          {
            "id": "56081cff-7a3e-4524-b7c1-e8e1fbcf18c1",
            "name": "Secondary Objective  Cohort 3 (18 Through 49 Years of Age)",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.4",
            "sectionTitle": "Secondary Objective  Cohort 3 (18 Through 49 Years of Age)"
          },
          {
            "id": "0836d02f-35b9-41d5-a278-37be07221dcd",
            "name": "Secondary Endpoint  Cohort 3 (18 Through 49 Years of Age)",
            "text": "",
            "order": 7,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.4.1",
            "sectionTitle": "Secondary Endpoint  Cohort 3 (18 Through 49 Years of Age)"
          },
          {
            "id": "3f9e2d9f-b893-4236-a09b-5e43c131f69f",
            "name": "Secondary Objective  All Cohorts",
            "text": "",
            "order": 8,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.5",
            "sectionTitle": "Secondary Objective  All Cohorts"
          },
          {
            "id": "a66043aa-0888-45ce-9ad9-ebe8ba776f84",
            "name": "Secondary Endpoints  All Cohorts",
            "text": "",
            "order": 9,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.5.1",
            "sectionTitle": "Secondary Endpoints  All Cohorts"
          },
          {
            "id": "3691f642-aa0c-4c28-96e8-704f60a635ea",
            "name": "Duration of Subject Participation",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "Duration of Subject Participation"
          },
          {
            "id": "e7d637a8-c97d-4d99-81a6-e3027ace63e3",
            "name": "Duration of the Study",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.2",
            "sectionTitle": "Duration of the Study"
          },
          {
            "id": "3013c967-600d-4a78-85d2-fa425489500f",
            "name": "Abbreviations",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "Appendix 1",
            "sectionTitle": "Abbreviations"
          }
        ],
        "abbreviations": [
          {
            "id": "9c06b3db-1058-43d4-960e-e7a57c6b5581",
            "abbreviatedText": "20vPnC",
            "expandedText": "20-valent Pneumococcal Conjugate Vaccine",
            "instanceType": "Abbreviation"
          },
          {
            "id": "286dd5b4-3f27-4b4c-8744-fe03b3b28c8c",
            "abbreviatedText": "MPA",
            "expandedText": "Medical Products Agency",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4f381725-dd9b-4d1f-9a16-67c223a1691e",
            "abbreviatedText": "EudraCT",
            "expandedText": "European Clinical Trials Database",
            "instanceType": "Abbreviation"
          },
          {
            "id": "5e95b8ac-41da-4ea1-9596-b4eeab19dd83",
            "abbreviatedText": "AOM",
            "expandedText": "acute otitis media",
            "instanceType": "Abbreviation"
          },
          {
            "id": "baf7eaa9-6bcd-489a-b041-6d1272d4ebf7",
            "abbreviatedText": "PPSV23",
            "expandedText": "23-valent pneumococcal polysaccharide vaccine",
            "instanceType": "Abbreviation"
          },
          {
            "id": "51417c0b-e92c-4402-8dfd-93ce59f7cb41",
            "abbreviatedText": "CAP",
            "expandedText": "community-acquired pneumonia",
            "instanceType": "Abbreviation"
          },
          {
            "id": "18625282-98af-4396-a9fe-fb4481b3a25d",
            "abbreviatedText": "13vPnC",
            "expandedText": "13-valent pneumococcal conjugate vaccine",
            "instanceType": "Abbreviation"
          },
          {
            "id": "740cb9d9-522d-4ad2-87bd-e0bcf1b6f4ce",
            "abbreviatedText": "CRM197",
            "expandedText": "cross-reactive material 197",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0b447215-f9d8-4b32-8261-e7a51479ae0c",
            "abbreviatedText": "VT",
            "expandedText": "vaccine-type",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0f55890c-4b8b-4736-8e4a-d150abc357c4",
            "abbreviatedText": "IPD",
            "expandedText": "invasive pneumococcal disease",
            "instanceType": "Abbreviation"
          },
          {
            "id": "532d3cd1-0b8b-43dc-964e-02d8f8a1f3b9",
            "abbreviatedText": "e-diary",
            "expandedText": "electronic diary",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ae98f884-f473-4a6c-a7b7-1dfa3dd3b2de",
            "abbreviatedText": "SAEs",
            "expandedText": "serious adverse events",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "c163362e-1113-4a2b-9b31-2298149c7c0b",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "d5fdebe3-f387-478c-a77b-e4a77804ad6c",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "2bb4962b-76ab-486c-958b-3eab42ee1fbb",
              "code": {
                "id": "2faed668-5984-41c7-bcc8-5f25202859c9",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "9ef9e741-df1a-4019-a318-ade9575495c5",
                "type": {
                  "id": "e43d34ba-2678-44c1-9b48-e5ae4cd7a257",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Added editorial changes throughout the document to improve clarity and to correct typographic errors. Revised the Protocol Summary and Schedule of Activities to expand the age range for Cohort 1 to include subjects 65 years of age and older. Added flexibility to clinical assessment wording, increased the number of study subjects, and added potential for investigator sites in Europe.",
            "effectiveDate": "2018-09-25",
            "reasonIds": [
              "2798b37d-47b3-41d7-a54a-7a252dd36ea7",
              "ebd9a712-08a9-45bb-8463-964758dfd145",
              "bddfc0fe-84cd-40cf-8e32-a9a3d19d8ccb"
            ],
            "previousVersion": "Original Protocol",
            "newVersion": "Amendment 1"
          },
          {
            "id": "9b3d4059-f27c-4962-8c8e-f555c33d3795",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "cbfde4e6-669b-41fa-8a5b-a90e7a202437",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "2fafd582-0ace-41ed-9bce-1e2f7f1f2ee8",
              "code": {
                "id": "29370ca7-9266-4e11-be36-72acc23b9e6f",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "6184bd04-6369-4011-bd7b-3c01b627973c",
                "type": {
                  "id": "f93bec06-b2f6-4317-b8cc-89a3f3a3d28d",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Section 1.3: Added benefit-risk assessment (country specific-amendment, required for Sweden by the Swedish Medical Products Agency [MPA]). European Clinical Trials Database (EudraCT) Number: Updated to 2018-004279-11.",
            "effectiveDate": "2019-02-11",
            "reasonIds": [
              "839aba32-f2d4-4bc4-897d-7a5c105f7d97"
            ],
            "previousVersion": "Amendment 1",
            "newVersion": "Amendment 2"
          }
        ],
        "medicalDevices": [
          {
            "id": "58e851a4-5f5a-4350-8b76-f11c378a6198",
            "name": "Prefilled Syringe",
            "instanceType": "MedicalDevice",
            "label": "PFS",
            "description": "Single-use prefilled syringe for vaccine administration.",
            "deviceType": {
              "id": "ab85c842-b990-496d-bdb5-b436a088e933",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "d5698039-f599-4365-bf96-bfef7a1e4af0",
            "name": "Electronic Diary",
            "instanceType": "MedicalDevice",
            "label": "e-diary",
            "description": "Device used by subjects to record local reactions and systemic events.",
            "deviceType": {
              "id": "2b78eb67-a7a0-4abf-a80c-19a974733275",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "7c1b6a26-9c6a-4ea9-a638-7a341ccee1ba",
            "name": "Digital Thermometer",
            "instanceType": "MedicalDevice",
            "label": "Thermometer",
            "description": "Device provided to subjects to measure oral temperature.",
            "deviceType": {
              "id": "26b6f5e5-70a7-4d10-8b70-89e96ca9e1e8",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "5fac9c44-e6b0-4bc7-814d-29f014304d5c",
            "name": "Measuring Device",
            "instanceType": "MedicalDevice",
            "label": "Caliper/Ruler",
            "description": "Device provided to subjects to measure injection site reactions (redness/swelling).",
            "deviceType": {
              "id": "986fd058-bf89-4a94-aca3-314dcecab756",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "602c8e2e-1175-40dc-8611-1562825f7c70",
            "name": "Vial",
            "instanceType": "MedicalDevice",
            "label": "Vaccine Vial",
            "description": "Packaging for PPSV23 and saline placebo.",
            "deviceType": {
              "id": "5ee1bf06-f308-4360-8006-5f0eca5aac05",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "25bd6566-7c6f-4264-81be-00f9b4573396",
            "name": "Febrile Illness Delay",
            "instanceType": "Condition",
            "description": "Criteria for delaying vaccination due to fever",
            "text": "Current febrile illness (body temperature >= 100.4F [38C]) or other acute illness within 48 hours before investigational product administration."
          },
          {
            "id": "8f74a4f8-176e-46d7-a400-7f6c7d441bcf",
            "name": "Corticosteroid Washout",
            "instanceType": "Condition",
            "description": "Delay required after short-term systemic corticosteroids",
            "text": "If systemic corticosteroids administered short term (<14 days), delay until therapy discontinued for at least 28 days."
          },
          {
            "id": "2a2a06b2-3cb5-48fc-b729-44f133c9baad",
            "name": "Vaccine Interference Delay",
            "instanceType": "Condition",
            "description": "Delay required after other vaccinations",
            "text": "Receipt of any inactivated vaccine within 14 days or any live vaccine within 28 days before investigational product administration."
          }
        ],
        "studySites": [
          {
            "id": "efb096b9-60c9-4dd7-bdb2-2bfd90c3d12d",
            "name": "Accel Research Sites",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "716a0648-e669-42c1-8a50-17c54188763c",
            "country": "United States"
          },
          {
            "id": "587c6e4d-6286-4654-8238-420be8bbd7b1",
            "name": "Coastal Clinical Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "1c8d2350-78b0-4a83-827c-041fc2f194b4",
            "country": "United States"
          },
          {
            "id": "21165809-28a9-4183-b213-b918e21ca496",
            "name": "East Valley Gastroenterology and Hepatology Associates",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "a2b1e0ce-954c-439f-8dfe-9905105a333c",
            "country": "United States"
          },
          {
            "id": "8028a677-1011-4c59-9b7d-603d6e24ea33",
            "name": "The Pain Center of Arizona",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "4d661582-62ee-45be-8a7b-739f986b2ae0",
            "country": "United States"
          },
          {
            "id": "2e22c0a8-3c84-4004-a144-eaebb4d6cee4",
            "name": "MedPharmics, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "0eb006e0-69b4-41d9-a6cc-797ee8103d66",
            "country": "United States"
          },
          {
            "id": "8944a64c-3648-4e6c-99ac-3035a8fb96b9",
            "name": "HOPE Research Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "9a76eae6-346b-4da9-9551-6015ccd6eea7",
            "country": "United States"
          },
          {
            "id": "556af514-3b43-4a4a-b233-327d4536f18d",
            "name": "The Pain Center of Arizona",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "306ec370-9e4a-46f9-82e7-47549c0217e2",
            "country": "United States"
          },
          {
            "id": "e70e636d-9027-4cdc-8c2b-79a057b4da7b",
            "name": "Anaheim Clinical Trials, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "234dc621-1d52-4741-be87-375dcbeec893",
            "country": "United States"
          },
          {
            "id": "747ed64e-dede-481d-aa1a-39ee50fde703",
            "name": "Diablo Clinical Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "f2105dbb-cc84-4bb6-9892-4c99164d2dd6",
            "country": "United States"
          },
          {
            "id": "5a5308d7-d1de-4d9f-8b0b-5b6b0f5ab71e",
            "name": "Clinical Research Consulting, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "327ae22b-3b61-4b2d-9295-13a02b86edb6",
            "country": "United States"
          },
          {
            "id": "691df05f-4538-4deb-8e74-1354d99c9e0a",
            "name": "Nature Coast Clinical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "7e170c10-05d9-4bf6-8e84-368f093aa398",
            "country": "United States"
          },
          {
            "id": "1130def3-5b65-408b-b770-b7e83d6bc921",
            "name": "Accel Research Sites - Clinical Research Unit",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "9e1c483e-0c44-4940-a9a0-b39da9b2c5fd",
            "country": "United States"
          },
          {
            "id": "734624f2-c8fb-47e3-bf7e-731ea559c2f6",
            "name": "Research Centers of America, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "b46f762b-683c-4ffb-85d5-7d15896736cf",
            "country": "United States"
          },
          {
            "id": "7de46de1-ba47-4e38-9e90-155c2f5cc9e2",
            "name": "Jacksonville Center for Clinical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "11d70155-dd56-47bb-94ea-16e641148cbe",
            "country": "United States"
          },
          {
            "id": "eca94780-0f05-405f-85fa-3647d2076c71",
            "name": "Suncoast Research Group, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "cb93eb67-526d-443d-adbb-8b1db7977ff0",
            "country": "United States"
          },
          {
            "id": "bb066cd3-6abf-4ca8-a55c-4ad7a462b4c0",
            "name": "Acevedo Clinical Research Associates",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "c4a5e1d1-9ca9-4f31-9c56-ae92edd53689",
            "country": "United States"
          },
          {
            "id": "373cb235-c790-49a6-b2b8-d0a716c2f72b",
            "name": "Qps-Mra, Llc",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "de1a0b48-a918-494d-8458-58981f3a5756",
            "country": "United States"
          },
          {
            "id": "45e260db-b73f-4dea-978c-285b4c230a77",
            "name": "Atlanta Center for Medical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "6f17a013-153e-47d6-b71f-e32deb5dcff8",
            "country": "United States"
          },
          {
            "id": "c3fc1e82-2e8a-47fb-809b-05d834e3ee6b",
            "name": "Meridian Clinical Research LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "7496cbee-a606-4efb-9d7e-0870e3932726",
            "country": "United States"
          },
          {
            "id": "091e17d1-fe72-42f4-a9e7-640af8eaad10",
            "name": "Clinical Research Atlanta",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "fc0e35fd-ff84-4571-9179-44a00e85d28b",
            "country": "United States"
          },
          {
            "id": "3f7b1b91-a427-45fe-af48-74db0a8c13d7",
            "name": "East-West Medical Research Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "d26d5315-0a0e-4d76-a1af-bbdff84f5381",
            "country": "United States"
          },
          {
            "id": "c63248b6-dd58-489b-886c-5cfdc9702fd6",
            "name": "Axtell Clinic, P.A.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "ebebcdb7-1cc2-4d46-9e53-3eeb1b8a0782",
            "country": "United States"
          },
          {
            "id": "a8f9757d-cbc1-4655-9bc6-c46f647c63d5",
            "name": "Heartland Research Associates, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "85713a4e-1843-4aa7-a314-6c78c56e5df0",
            "country": "United States"
          },
          {
            "id": "10fa9dfc-39a6-42ac-8888-b12777157b65",
            "name": "Heartland Research Associates, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "686acbdb-e696-4f73-ad9c-7b159aa7f99f",
            "country": "United States"
          },
          {
            "id": "970553b3-d7a6-46e9-a6f2-1d67ea3210a4",
            "name": "Northwest Family Physicians",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "c629e5c8-f803-4346-b1ac-e0034870b044",
            "country": "United States"
          },
          {
            "id": "f63a85f4-f976-4c06-ba5f-31bc30adf464",
            "name": "Heartland Research Associates, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "d5358c93-9021-4c83-9248-7a73788c17e6",
            "country": "United States"
          },
          {
            "id": "d0ad8ad5-fba0-4618-bef0-91674331087c",
            "name": "Meridian Clinical Research, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "94d7e426-1344-49df-9a65-06448d3f1768",
            "country": "United States"
          },
          {
            "id": "3189e034-82de-4d6f-8e14-e7bb4fb46153",
            "name": "Sundance Clinical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "34f6e17a-ec51-40b1-b70f-4601184fcbde",
            "country": "United States"
          },
          {
            "id": "cd86d76a-f4ba-4dc3-9136-48f984a99b49",
            "name": "Meridian Clinical Research, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "dd546f88-4946-4ed3-bac8-17ba18fa8bd6",
            "country": "United States"
          },
          {
            "id": "bf075854-64f9-4c9b-809e-14484d62472a",
            "name": "Meridian Clinical Research LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "2fb809a0-1070-43fe-aa80-fa411259e0e2",
            "country": "United States"
          },
          {
            "id": "81609eef-5eb7-48ef-90de-43c55dc47f0a",
            "name": "ActivMed Practices & Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "dda234f0-d4f1-4dbe-93c8-5339a2d3ab71",
            "country": "United States"
          },
          {
            "id": "d2001613-ae53-4d69-8084-89d88bfc099d",
            "name": "United Medical Associates",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "003d8207-3b1f-48a3-8756-97bbca965d9b",
            "country": "United States"
          },
          {
            "id": "26992d2b-5f91-4944-901b-b7947e3e4db2",
            "name": "Regional Clinical Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "96ce8e71-35a7-4670-af0d-1621eac565a0",
            "country": "United States"
          },
          {
            "id": "7e1af328-d857-4c6b-b1e1-824cc56c9b84",
            "name": "Rochester Clinical Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "8aaf265b-69be-4ccd-983a-e18848b32388",
            "country": "United States"
          },
          {
            "id": "7ab0f54b-3e83-4583-bc37-9789ae2f80ba",
            "name": "PharmQuest",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "9abc1939-efed-44e5-b4b6-166abb05a0b9",
            "country": "United States"
          },
          {
            "id": "13b863b1-f134-497c-ad01-120aa2f0a7d9",
            "name": "M3 Wake Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "78998cfd-fd0a-4d3b-8733-5d05a9777719",
            "country": "United States"
          },
          {
            "id": "e62f47a3-4b42-41a7-8e27-5930e03acfff",
            "name": "PMG Research of Wilmington, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "caa132f1-e3fe-4612-b199-1d3db8544066",
            "country": "United States"
          },
          {
            "id": "912690cd-9f64-4664-8b87-11ad0442c689",
            "name": "Lillestol Research LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "644a5c0a-2c22-4dbb-9d27-14b878faab1d",
            "country": "United States"
          },
          {
            "id": "7424e5a1-111e-4a4d-8fe2-f8bc8995c739",
            "name": "Cincinnati Children's Hospital Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "ce986e82-13e9-4fa4-a881-5597d73ae1e1",
            "country": "United States"
          },
          {
            "id": "afa3fa3d-9878-4c92-a352-2ab16c0dea1d",
            "name": "Sterling Research Group, Ltd.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "82e9a53b-6f02-4fe3-b6ee-3722145d1afa",
            "country": "United States"
          },
          {
            "id": "a9d23356-9360-41d6-9c71-1b09d51932c2",
            "name": "Cincinnati Children's Hospital Medical Center (CCHMC)",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "23ae8c87-1fc1-4b45-9f9b-a507b8be569b",
            "country": "United States"
          },
          {
            "id": "f8135015-8bc5-4ce4-a68a-00b76696579a",
            "name": "Sterling Research Group, Ltd.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "920d19b9-9943-4e6c-8064-66daf19c4126",
            "country": "United States"
          },
          {
            "id": "b9174e45-509d-4e3f-86af-c16f909ec59e",
            "name": "Rapid Medical Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "aabe995d-2261-4ae7-a55c-07e15c78643f",
            "country": "United States"
          },
          {
            "id": "be827f5e-bf35-4e40-9307-2ceb9d4bbf59",
            "name": "Lynn Health Science Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "ab9d16ab-1e4e-4168-8c42-71fde5f1fbf7",
            "country": "United States"
          },
          {
            "id": "a28ed102-21dd-479c-ae23-9ce20ae96c85",
            "name": "Omega Medical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "b92ef709-97f4-4149-b1f8-86bab5886ae2",
            "country": "United States"
          },
          {
            "id": "79505ed1-f1e5-45dc-b806-f3690b5928f9",
            "name": "Meridian Clinical Research, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "1979fb86-fd37-4d70-b389-5c75825e8fd9",
            "country": "United States"
          },
          {
            "id": "94da16a8-3687-4bb3-a69e-0cf86d328134",
            "name": "Tekton Research, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "3352db92-b84e-4e0f-aa52-d1b6e143286d",
            "country": "United States"
          },
          {
            "id": "29d1da0e-2d51-445e-a3ed-21e88c35cbe4",
            "name": "Bellaire Doctor's Clinic",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "12fabfb2-77da-43cd-b000-5c996f828f6a",
            "country": "United States"
          },
          {
            "id": "c86e6a9c-fdb9-488c-b7f7-207cc2c2bbe7",
            "name": "Ventavia Research Group, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "9c9e6438-b362-49ff-9a69-5cf5f515b991",
            "country": "United States"
          },
          {
            "id": "ee9ca144-049e-4216-bf5f-ffe15a02c218",
            "name": "Benchmark Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "663db969-ebef-4bc1-9319-b08c4f3a9a6a",
            "country": "United States"
          },
          {
            "id": "0e90bf44-1f92-4d4b-8931-f2e5e5254183",
            "name": "HealthFirst Medical Group",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "51",
            "organizationId": "14d77418-a6cc-4551-9fb3-9db45ae45804",
            "country": "United States"
          },
          {
            "id": "0037816f-ad3a-4d8c-9f89-a79bd6db3af3",
            "name": "Ventavia Research Group, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "52",
            "organizationId": "043a9331-fe4d-44ae-9ccc-fdbc2e4be3ea",
            "country": "United States"
          },
          {
            "id": "2c85f08d-e611-4df6-976f-2677582326ef",
            "name": "Clinical Trials of Texas, Inc.",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "53",
            "organizationId": "ad559c39-469b-476b-bcb9-9000ade2fbc9",
            "country": "United States"
          },
          {
            "id": "533ee84c-6bb8-4797-a154-49de420f74f3",
            "name": "Ventavia Research Group, LLC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "54",
            "organizationId": "7a97f47b-60a2-4ed3-a650-2cf3ae1d6c47",
            "country": "United States"
          },
          {
            "id": "789c1d28-58ef-4924-9827-4ea83c8f73ad",
            "name": "DM Clinical Research",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "55",
            "organizationId": "832418e3-d786-4452-a70e-36d6ad002cb2",
            "country": "United States"
          },
          {
            "id": "85b9ddc1-eff7-4155-af96-cd05a3b66fd8",
            "name": "Martin Diagnostic Clinic",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "56",
            "organizationId": "d6ded488-aea7-4794-823e-c34200d2d134",
            "country": "United States"
          },
          {
            "id": "b5b21fef-c86f-4c13-9050-2babf932ce13",
            "name": "J. Lewis Research Inc. / Foothill Family Clinic Draper",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "57",
            "organizationId": "9bcd7450-e2ec-4588-a65b-b88bb00c0af8",
            "country": "United States"
          },
          {
            "id": "b4628f14-9ba7-4e0d-9595-96b3a0f806e0",
            "name": "J. Lewis Research, Inc. / Foothill Family Clinic",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "58",
            "organizationId": "522c8baf-6696-4454-8005-1923f97219c8",
            "country": "United States"
          },
          {
            "id": "fa5a6da3-d449-4227-b591-e272d4c90ef0",
            "name": "J. Lewis Research, Inc. / Foothill Family Clinic South",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "59",
            "organizationId": "0c6a3e2b-4a5f-4479-866f-796585be3453",
            "country": "United States"
          },
          {
            "id": "8b998a1b-f6d8-4ad6-948b-c4349f915cd1",
            "name": "J. Lewis Research, Inc. - Jordan River Family Medicine",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "60",
            "organizationId": "26115327-5894-456e-b46c-bafe74f7a950",
            "country": "United States"
          },
          {
            "id": "32530581-2b44-4edd-a859-4e294f473101",
            "name": "Kaiser Permanente Washington Health Research Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "61",
            "organizationId": "7774cfdd-f6a5-4def-ad66-6eeb87bfcabf",
            "country": "United States"
          },
          {
            "id": "3894c0ee-899a-4c61-a07a-186a1f176453",
            "name": "Ladulaas Kliniska Studier",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "62",
            "organizationId": "3f59ae4c-76dc-4d14-b068-ab751abfcd88",
            "country": "Sweden"
          },
          {
            "id": "2eb681a0-4d8c-430c-9d12-ab30b64eb12b",
            "name": "Infektionskliniken Malarsjukhuset",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "63",
            "organizationId": "1398a5b5-8185-4226-a705-95438a6a015a",
            "country": "Sweden"
          },
          {
            "id": "cd2d0bbf-d245-46ed-b88d-5adadbb7cd1a",
            "name": "ProbarE i Lund",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "64",
            "organizationId": "d1a34c76-79e9-4d73-85b4-a64edcafca90",
            "country": "Sweden"
          },
          {
            "id": "cf8c5d9a-cc67-4c77-b922-060c9cd6231b",
            "name": "Avdelningen fr kliniska prvningar",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "65",
            "organizationId": "9b5960f5-93b1-4c2d-9156-05274f8cfc7b",
            "country": "Sweden"
          },
          {
            "id": "47be9c4f-4feb-4434-a0f4-c6d436a42f96",
            "name": "Karolinska Trial Alliance, KTA Prim",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "66",
            "organizationId": "a6588d2c-5423-4fad-9aa2-df689c6ce8eb",
            "country": "Sweden"
          },
          {
            "id": "4b6a2a61-00c9-4bd9-b5aa-6fa7d3d3f7c9",
            "name": "Akardo Med Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "67",
            "organizationId": "eec2f315-eded-4794-acc9-6d40ddae4d40",
            "country": "Sweden"
          },
          {
            "id": "9c8bd510-08c4-4306-ab7d-971e799166d2",
            "name": "Akademiska Sjukhuset",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "68",
            "organizationId": "203e58e0-8b00-444c-a100-8e35c9fc947c",
            "country": "Sweden"
          }
        ],
        "administrations": [
          {
            "id": "2fe87afc-d3a8-4d33-983b-05db0ce5d3fa",
            "name": "Administration of 20-valent Pneumococcal Conjugate Vaccine (20vPnC) / PF-06482077",
            "description": "RouteOfAdministration.INTRAMUSCULAR DosingFrequency.SINGLE_DOSE",
            "instanceType": "Administration",
            "route": {
              "id": "7da420fe-cb27-4a2d-b85e-14b48f21a65c",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "IM",
              "instanceType": "Code"
            }
          },
          {
            "id": "a5df8df8-a005-46ff-a7ae-7863afe040b1",
            "name": "Administration of Comparator / Placebo",
            "description": "RouteOfAdministration.INTRAMUSCULAR DosingFrequency.SINGLE_DOSE",
            "instanceType": "Administration",
            "route": {
              "id": "462df939-9b47-444b-b5d6-737ae6be5840",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "IM",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINENAVE ADULTS 18 YEARS OF AGE AND OLDER"
  },
  "administrations": [
    {
      "id": "d37c02a7-7206-4010-afc9-671b587effd2",
      "name": "20vPnC Administration",
      "instanceType": "Administration",
      "dose": "0.5 mL",
      "doseFrequency": "Single dose",
      "route": {
        "id": "2438bb2c-ebf9-4138-ae43-713a6582b96f",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Day 1"
    },
    {
      "id": "c5ad2762-3b37-4e83-a343-92e41de53dfa",
      "name": "13vPnC Administration (Cohort 1 Control)",
      "instanceType": "Administration",
      "dose": "0.5 mL",
      "doseFrequency": "Single dose",
      "route": {
        "id": "cfd39345-4cc3-4100-9a43-718c02831aaf",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Day 1"
    },
    {
      "id": "d4bf29f2-7275-41f5-a25e-45ab6af54dd7",
      "name": "PPSV23 or Saline Administration (Cohort 1)",
      "instanceType": "Administration",
      "dose": "0.5 mL",
      "doseFrequency": "Single dose",
      "route": {
        "id": "423a30eb-f9f6-4c80-bb38-03ed59c64ae3",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "28 to 42 days after Vaccination 1"
    }
  ],
  "substances": [
    {
      "id": "b62052bf-2eba-4141-ae53-18611f9948ac",
      "name": "20-valent Pneumococcal Conjugate Vaccine",
      "instanceType": "Substance",
      "description": "Saccharides from 20 pneumococcal serotypes conjugated to CRM197"
    },
    {
      "id": "190d0b35-fa69-4a76-8adb-33a026257aed",
      "name": "13-valent Pneumococcal Conjugate Vaccine",
      "instanceType": "Substance",
      "description": "Saccharides from 13 pneumococcal serotypes conjugated to CRM197"
    },
    {
      "id": "6a9dd8ef-8d42-435c-a4f6-59922d581fa9",
      "name": "Pneumococcal Vaccine, Polyvalent",
      "instanceType": "Substance",
      "description": "Purified capsular polysaccharides from 23 serotypes"
    }
  ],
  "studyDefinitionDocument": {
    "id": "d8c06e2c-4b92-43af-aac1-a89051b9b8bf",
    "name": "20-valent Pneumococcal Conjugate Vaccine (20vPnC)",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Final Protocol Amendment 2",
    "versionDate": "11 February 2019",
    "contentIds": [
      "ce816973-74e6-4fd9-8d6c-a3e13aed167f",
      "14b4b2b6-d776-416e-a3ad-ef428aefdd44",
      "0e5c412b-a614-46ac-a16f-81a869a843a4",
      "a7af0c60-333d-4f32-b1ab-2b5a77eb48b6",
      "5d71057c-ffce-4d10-884f-c0c3ef862f95",
      "41a7e764-173d-4bf7-8548-81781ae66350",
      "ec9dea0e-60be-4f54-8672-53f416773145"
    ]
  },
  "geographicScope": {
    "id": "d80ae80b-f395-416b-b6cc-dacb9378f3f8",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "7fd42c3d-0a40-4f2e-99bb-7e991bef9e30",
      "68542c5c-86ba-4c1f-933e-2b7c04ae55c5"
    ],
    "regions": [
      "North America",
      "Europe"
    ]
  },
  "countries": [
    {
      "id": "7fd42c3d-0a40-4f2e-99bb-7e991bef9e30",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "68542c5c-86ba-4c1f-933e-2b7c04ae55c5",
      "name": "Sweden",
      "instanceType": "Country",
      "code": "SE"
    }
  ],
  "ingredients": [
    {
      "id": "deb47c0a-5ea8-4c65-9514-aee8a55d78db",
      "name": "20-valent Pneumococcal Conjugate Vaccine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "20vPnC"
    },
    {
      "id": "91be3808-6cee-4d8e-9cd3-098bdbb75b0c",
      "name": "13-valent Pneumococcal Conjugate Vaccine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "13vPnC"
    },
    {
      "id": "320bba18-3b37-4299-9534-d900a4edf37c",
      "name": "Pneumococcal Polysaccharide Vaccine (23-valent)",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "PPSV23"
    },
    {
      "id": "1319386a-c70e-4c29-b426-2b7d2b153150",
      "name": "Sodium Chloride",
      "role": "Inactive",
      "instanceType": "Ingredient",
      "substanceId": "Saline"
    },
    {
      "id": "c874ed80-f2f5-4719-a539-3a6d8e100de2",
      "name": "Phenol",
      "role": "Inactive",
      "instanceType": "Ingredient",
      "substanceId": "Preservative"
    }
  ],
  "strengths": [
    {
      "id": "e093d2ca-7a73-44c7-9697-371fd55e534f",
      "instanceType": "Strength",
      "value": 0.5,
      "unit": "mL",
      "numerator": {
        "value": 0.5,
        "unit": "mL"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "18af6834-c5f2-4e29-98f7-d399d7d8786f",
      "instanceType": "Strength",
      "value": 25,
      "unit": "ug",
      "numerator": {
        "value": 25,
        "unit": "ug"
      },
      "denominator": {
        "value": 0.5,
        "unit": "mL"
      }
    },
    {
      "id": "ef443df6-c4eb-4fa9-86f2-15eb7e2b7a22",
      "instanceType": "Strength",
      "value": 0.9,
      "unit": "%",
      "numerator": {
        "value": 0.9,
        "unit": "g"
      },
      "denominator": {
        "value": 100,
        "unit": "mL"
      }
    },
    {
      "id": "837c5079-c0b0-4a89-a6dc-993219811ac9",
      "instanceType": "Strength",
      "value": 0.25,
      "unit": "%",
      "numerator": {
        "value": 0.25,
        "unit": "g"
      },
      "denominator": {
        "value": 100,
        "unit": "mL"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "062506be-9754-40b4-a1aa-27d724769d59",
      "name": "Screening to Vaccination",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "31012a89-dd67-45d3-b977-bf91ebf47329",
      "toElementId": "d5282038-2df7-4587-b990-fc6f9a607481",
      "text": "Subject must meet all eligibility criteria and have negative urine pregnancy test immediately before administration."
    },
    {
      "id": "870c40c7-76e0-49ce-b530-3af5681038b0",
      "name": "Withdrawal for Safety",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Investigator or sponsor may withdraw subject for safety reasons, adverse events, or pregnancy."
    }
  ],
  "documentContentReferences": [
    {
      "id": "7b784516-9ecc-44a0-be99-dcf554700122",
      "name": "Benefit-Risk Assessment",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "1.3",
      "sectionTitle": "Benefit-Risk Assessment",
      "description": "Cross-reference to country-specific amendment for Sweden"
    },
    {
      "id": "35268ff0-7896-4c0a-bfaa-93b3ab168e01",
      "name": "Nonstudy Vaccinations and Medications",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.13",
      "sectionTitle": "Nonstudy Vaccinations and Medications",
      "description": "Reference for recording concomitant medications and vaccinations"
    },
    {
      "id": "ed7bc2de-afc4-4717-b22e-66160f46cc88",
      "name": "Contraception Check",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.4.1",
      "sectionTitle": "Contraception Check",
      "description": "Reference for performing contraception checks"
    },
    {
      "id": "5bd29c7b-ef50-4813-a542-a8800d845835",
      "name": "AE/SAE/NDCMC Recording",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.1.4",
      "sectionTitle": "Reporting of AEs, SAEs, and NDCMCs",
      "description": "Reference for recording safety events in the CRF"
    },
    {
      "id": "4ad18ae8-f084-4303-8d90-e119d41aca9f",
      "name": "Grade 4 Reactions",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.3",
      "sectionTitle": "Emergency Contact for Grade 4 Reactions",
      "description": "Reference for reporting severe prompted reactions"
    },
    {
      "id": "605dfebe-ab60-4d1f-9c5e-9e9b3a5fcdde",
      "name": "Pregnancy Testing",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.1",
      "sectionTitle": "Urine Pregnancy Test",
      "description": "Reference for female subjects of childbearing potential"
    },
    {
      "id": "20efbc4d-dbc1-45ee-b667-90428dd04a1c",
      "name": "Fever Ranges",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Table 7",
      "sectionTitle": "Ranges for Fever",
      "description": "Reference for temperature range adjustments"
    }
  ],
  "commentAnnotations": [
    {
      "id": "1b697fbb-6f55-4058-b598-e5544b2d5b91",
      "text": "Record nonstudy vaccinations and concomitant medications",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schedule of Activities",
      "pageNumber": 16
    },
    {
      "id": "08be8a25-f56d-4ffa-b0af-ca2e69fbfe80",
      "text": "Contraception check, if applicable",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schedule of Activities",
      "pageNumber": 16
    },
    {
      "id": "d2bb3a54-3ebf-4fc3-8fae-308655d124cb",
      "text": "Obtain blood sample for immunogenicity (~50 mL)",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schedule of Activities",
      "pageNumber": 16
    },
    {
      "id": "759e3b4a-7a2c-4f38-b32f-3c26472ca0b5",
      "text": "Prophylactic antipyretic/pain medication is not recommended on the day of vaccination",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "6.1.1",
      "pageNumber": 41
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "0e3b86a2-6e4d-444f-b111-37489b86715c",
      "versionNumber": "Amendment 2",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2019-02-11",
      "description": "Added benefit-risk assessment for Sweden and updated EudraCT number",
      "amendmentNumber": "2"
    },
    {
      "id": "d2e427bc-bc86-4b59-bdef-b3e2bf75eb50",
      "versionNumber": "Amendment 1",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2018-09-25",
      "description": "Expanded age range for Cohort 1 and added editorial changes",
      "amendmentNumber": "1"
    },
    {
      "id": "308a50de-e885-4d18-9a07-d09f2ec83726",
      "versionNumber": "Original Protocol",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2018-07-13",
      "description": "Initial release",
      "amendmentNumber": "N/A"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "f504767b-ae69-48a6-ad04-ee0bbb372833",
      "amendmentId": "9b3d4059-f27c-4962-8c8e-f555c33d3795",
      "affectedSection": "Section 1.3 - Benefit-Risk Assessment",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added benefit-risk assessment specifically for Sweden."
    },
    {
      "id": "4602266b-3701-48ce-9b37-9b27d7be0fcc",
      "amendmentId": "9b3d4059-f27c-4962-8c8e-f555c33d3795",
      "affectedSection": "Global/Administrative",
      "impactLevel": "Administrative",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updated EudraCT number to 2018-004279-11."
    },
    {
      "id": "c085cf50-45a6-41e2-81d2-333de0685f9a",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "affectedSection": "Schedule of Activities",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Expanded age range for Cohort 1 and added clinical assessment flexibility."
    },
    {
      "id": "96116d59-d7a7-430e-879b-2f01840c10f9",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "affectedSection": "Section 3 - Study Design",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Increased sample size and added European investigator sites."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "61a51539-2e71-4aab-af2b-56d476a9f4eb",
      "amendmentId": "9b3d4059-f27c-4962-8c8e-f555c33d3795",
      "reasonText": "Required for Sweden by the Swedish Medical Products Agency (MPA)",
      "category": "Regulatory",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "fbb3682b-2b30-4dd4-8767-bc730ae2533b",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "reasonText": "Improve clarity and correct typographic errors",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "148986cf-5a01-4cea-b455-2ac8536a9d3e",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "reasonText": "Incorporation of revisions requested by country health authorities and IRBs/ECs",
      "category": "Regulatory",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "abd3b834-41d9-4a2d-80cd-cac37ccff2b1",
      "amendmentId": "9b3d4059-f27c-4962-8c8e-f555c33d3795",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "afterText": "Benefit-risk assessment (country specific-amendment, required for Sweden)",
      "summary": "Added benefit-risk assessment for Swedish MPA compliance."
    },
    {
      "id": "0ddef0ca-172d-4ea1-b27c-f51d766ecb61",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.1",
      "beforeText": "Cohort 1 age range (original)",
      "afterText": "Cohort 1 age range to include subjects 65 years of age and older",
      "summary": "Expanded Cohort 1 to include subjects 65+."
    },
    {
      "id": "21a3f5dc-bbfb-4242-b205-67f5266b3dcb",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "7.2",
      "beforeText": "Temperature ranges with gaps and Fahrenheit units",
      "afterText": "Removed Fahrenheit and adjusted temperature ranges to close gaps",
      "summary": "Standardized temperature reporting and removed gaps in data ranges."
    },
    {
      "id": "75920992-1b2f-42d0-9cd2-995bd944dfdb",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "8",
      "afterText": "Instruction for the investigator to contact the sponsor or designee for SAEs occurring within 30 days after vaccination",
      "summary": "Added specific reporting instructions for SAEs."
    },
    {
      "id": "673a7112-3a16-4da6-a9a4-c545023a8022",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "9.1.2",
      "afterText": "Immunogenicity bridging analysis will be performed between each of Cohort 2 and Cohort 3 and the subset of subjects 60 through 64 years of age in Cohort 1",
      "summary": "Clarified the specific age subset for immunogenicity bridging."
    },
    {
      "id": "09267d43-3f2c-4d43-9792-708d43869efa",
      "amendmentId": "c163362e-1113-4a2b-9b31-2298149c7c0b",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1",
      "beforeText": "Standard clinical assessment",
      "afterText": "Physical examination based on medical history",
      "summary": "Revised scope of clinical assessment to allow for history-based exams."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}